data_1ba6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ba6 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 110.586 -0.153 . . . . 0.0 110.586 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.1 tp -41.29 -49.82 3.69 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.503 ' CG2' ' H ' ' A' ' 19' ' ' PHE . 31.0 m -51.81 -60.83 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 124.045 0.841 . . . . 0.0 110.923 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.503 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 32.2 m-85 -60.19 -44.92 94.7 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.702 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -49.6 -8.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 124.974 1.421 . . . . 0.0 113.752 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.415 ' H ' ' C ' ' A' ' 19' ' ' PHE . . . -118.23 -53.52 2.35 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -54.89 -38.29 67.38 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.07 -37.96 78.78 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.443 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -61.92 -47.58 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 105.21 -2.145 . . . . 0.0 105.21 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.77 -46.68 93.65 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.486 1.367 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.916 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 pp -49.28 -40.63 35.3 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.4 m -60.44 -54.44 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.709 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -57.98 -44.93 87.4 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.477 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -46.95 -17.73 0.06 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 114.563 -1.198 . . . . 0.0 113.977 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -123.22 -44.18 2.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 123.799 0.687 . . . . 0.0 111.117 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -71.91 -51.92 19.79 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.766 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.29 -41.28 94.3 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.889 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.9 m -63.31 -36.39 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.05 -49.33 76.15 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.9 p . . . . . 0 N--CA 1.49 1.54 0 O-C-N 123.943 0.437 . . . . 0.0 112.045 179.891 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? . . . . . 0 N--CA 1.497 1.886 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.35 -34.56 10.88 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 123.781 0.676 . . . . 0.0 110.569 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.474 ' CG2' ' H ' ' A' ' 19' ' ' PHE . 35.5 m -58.71 -60.87 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.018 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.474 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 24.0 m-85 -56.72 -40.75 76.23 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.521 0.677 . . . . 0.0 110.318 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -45.88 -23.29 0.27 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.297 -1.32 . . . . 0.0 114.097 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.07 -39.72 2.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 123.753 0.658 . . . . 0.0 110.571 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -73.37 -53.5 10.6 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.106 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.19 -36.07 82.86 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.1 m -61.75 -38.94 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.57 -54.13 36.31 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.579 -2.208 . . . . 0.0 107.579 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.858 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.635 0.255 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 pp -46.72 -33.58 4.44 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.895 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.436 ' CG2' ' H ' ' A' ' 19' ' ' PHE . 34.0 m -62.19 -57.03 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 O-C-N 123.877 0.735 . . . . 0.0 109.53 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.436 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 31.2 m-85 -59.46 -41.92 90.79 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.342 0.591 . . . . 0.0 110.319 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -48.57 -16.06 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 114.317 -1.31 . . . . 0.0 114.138 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -125.85 -43.78 1.83 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 123.738 0.649 . . . . 0.0 110.655 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -73.17 -53.68 10.37 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.773 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.24 -40.19 93.71 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 117.924 -1.036 . . . . 0.0 112.191 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.2 m -60.01 -37.33 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.92 -51.41 59.34 Favored Glycine 0 N--CA 1.489 2.171 0 CA-C-N 113.097 -1.865 . . . . 0.0 109.064 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.497 1.879 0 O-C-N 124.629 0.841 . . . . 0.0 111.212 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 121.721 0.772 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.7 tt -52.5 -25.96 11.72 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.107 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.403 ' CG2' ' H ' ' A' ' 19' ' ' PHE . 33.3 m -65.77 -53.98 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.403 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 27.8 m-85 -59.11 -41.6 88.55 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.715 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -46.45 -19.17 0.07 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 114.19 -1.368 . . . . 0.0 113.589 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -127.46 -40.53 1.78 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 123.566 0.541 . . . . 0.0 111.067 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -75.21 -49.58 18.92 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.532 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.16 -39.75 86.55 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.939 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.3 m -61.36 -37.43 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.79 -45.74 95.1 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.8 m . . . . . 0 N--CA 1.489 1.522 0 CA-C-N 115.042 -0.579 . . . . 0.0 111.156 179.776 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.1 pp -51.65 -41.02 61.03 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.405 ' CG2' ' H ' ' A' ' 19' ' ' PHE . 26.7 m -58.67 -60.9 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.355 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.405 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 19.6 m-30 -61.01 -37.3 82.06 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -47.39 -19.9 0.19 Allowed 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -120.21 -43.76 2.52 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 123.902 0.751 . . . . 0.0 109.259 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -69.19 -57.52 5.26 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.575 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.92 -36.63 81.93 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.0 m -63.81 -38.72 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.92 -51.04 61.05 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 107.451 -2.26 . . . . 0.0 107.451 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.487 1.38 0 O-C-N 124.348 0.675 . . . . 0.0 109.4 179.852 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 tt -44.53 -32.16 1.33 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 123.892 0.745 . . . . 0.0 112.5 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.506 ' CG2' ' H ' ' A' ' 19' ' ' PHE . 31.8 m -66.53 -59.6 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.75 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.506 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 32.5 m-85 -57.23 -38.14 73.34 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.164 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -39.11 -31.37 0.07 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.176 -1.375 . . . . 0.0 112.828 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.33 -49.23 2.05 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 124.546 1.154 . . . . 0.0 109.925 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -58.95 -47.39 85.25 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.46 -0.496 . . . . 0.0 112.209 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.47 -38.68 90.78 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 118.964 -1.095 . . . . 0.0 111.846 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -55.49 -47.62 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.48 -49.72 67.39 Favored Glycine 0 N--CA 1.489 2.184 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.931 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.499 1.984 0 CA-C-O 121.308 0.575 . . . . 0.0 110.549 179.895 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 pp -48.03 -32.56 6.78 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.725 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.446 ' CG2' ' H ' ' A' ' 19' ' ' PHE . 33.6 m -62.33 -57.81 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 123.696 0.623 . . . . 0.0 109.663 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.446 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 32.1 m-85 -60.32 -42.94 96.66 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.419 0.628 . . . . 0.0 110.738 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -50.64 -13.33 0.13 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -126.81 -42.67 1.75 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 123.483 0.489 . . . . 0.0 110.806 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -77.16 -51.85 10.27 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.379 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.71 -40.41 96.71 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 117.963 -1.017 . . . . 0.0 112.543 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.6 m -57.25 -36.75 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.89 -50.42 52.97 Favored Glycine 0 N--CA 1.487 2.035 0 CA-C-N 112.946 -1.934 . . . . 0.0 108.763 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.9 m . . . . . 0 N--CA 1.497 1.902 0 O-C-N 124.24 0.612 . . . . 0.0 112.051 179.973 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -46.86 -30.55 2.55 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.225 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.451 ' CG2' ' H ' ' A' ' 19' ' ' PHE . 34.1 m -63.86 -58.01 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.451 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 25.6 m-85 -58.29 -40.28 81.52 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.125 0.488 . . . . 0.0 110.867 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -45.2 -23.83 0.21 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 114.774 -1.103 . . . . 0.0 113.622 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.08 -40.52 2.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 123.734 0.646 . . . . 0.0 111.09 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -71.51 -51.13 25.28 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.929 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -62.14 -44.74 95.95 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.705 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.7 m -57.22 -35.05 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 118.901 -1.12 . . . . 0.0 107.981 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.89 -45.28 64.54 Favored Glycine 0 CA--C 1.544 1.901 0 CA-C-N 112.837 -1.983 . . . . 0.0 110.862 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.9 p . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -179.787 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 120.549 0.214 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.3 mt -42.58 -33.52 0.71 Allowed 'General case' 0 N--CA 1.5 2.054 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.895 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.471 ' CG2' ' H ' ' A' ' 19' ' ' PHE . 34.4 m -63.5 -59.83 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.471 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 25.8 m-85 -56.65 -37.44 70.79 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.507 0.67 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -42.59 -26.29 0.12 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 113.865 -1.516 . . . . 0.0 113.158 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -124.3 -42.71 2.1 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 124.167 0.917 . . . . 0.0 110.077 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -67.22 -50.85 59.19 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.275 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -61.37 -33.76 74.18 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.697 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.445 HG21 ' N ' ' A' ' 25' ' ' GLY . 2.9 m -54.76 -42.01 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.445 ' N ' HG21 ' A' ' 24' ' ' VAL . . . -69.55 -49.26 38.6 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 179.959 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 30.1 t70 . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.32 53.37 1.3 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 124.555 1.16 . . . . 0.0 111.159 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -89.12 38.87 0.91 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.495 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -64.7 148.71 50.52 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.022 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.41 ' C ' ' H ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -137.17 43.64 2.34 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.645 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.6 33.09 0.36 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.806 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 5' ' ' ARG . 0.1 OUTLIER -62.37 124.73 21.7 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.52 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.0 m -65.85 -169.9 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.356 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.15 -57.82 0.78 Allowed Glycine 0 N--CA 1.497 2.748 0 N-CA-C 105.481 -3.047 . . . . 0.0 105.481 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -124.53 36.58 4.58 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -168.49 162.08 12.03 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 112.694 -2.048 . . . . 0.0 108.928 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -60.97 151.83 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.622 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.465 ' CD2' HE22 ' A' ' 15' ' ' GLN . 17.4 t-80 -99.96 28.73 4.62 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.23 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -100.89 46.23 0.95 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.953 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.498 HE21 ' H ' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -62.43 -4.52 1.92 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.832 179.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.68 -41.84 23.03 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.586 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.1 tp -41.29 -49.82 3.69 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.503 ' CG2' ' H ' ' A' ' 19' ' ' PHE . 31.0 m -51.81 -60.83 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 124.045 0.841 . . . . 0.0 110.923 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.503 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 32.2 m-85 -60.19 -44.92 94.7 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.702 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -49.6 -8.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 124.974 1.421 . . . . 0.0 113.752 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.415 ' H ' ' C ' ' A' ' 19' ' ' PHE . . . -118.23 -53.52 2.35 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -54.89 -38.29 67.38 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.07 -37.96 78.78 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.443 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -61.92 -47.58 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 105.21 -2.145 . . . . 0.0 105.21 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.77 -46.68 93.65 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.1 t -92.29 40.22 1.04 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -48.65 150.05 1.52 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 114.953 -1.021 . . . . 0.0 113.102 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.74 43.09 0.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 113.76 -1.564 . . . . 0.0 107.046 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.46 20.8 18.19 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.16 20.69 3.5 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 124.542 0.79 . . . . 0.0 112.41 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 55.9 mt -55.27 -26.96 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.055 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.5 tt -50.25 -30.48 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 124.442 1.089 . . . . 0.0 111.854 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.33 -39.68 1.61 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 107.248 -2.341 . . . . 0.0 107.248 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 57.76 32.9 22.55 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 122.176 0.989 . . . . 0.0 111.083 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.2 p -60.09 -42.44 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.373 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.82 36.1 0.45 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.07 49.72 0.19 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.3 t -97.14 34.24 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 115.049 -2.405 . . . . 0.0 111.178 -179.999 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 t70 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 122.016 0.913 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -170.44 62.83 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -121.22 10.57 10.67 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 112.886 -1.961 . . . . 0.0 110.837 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -63.91 125.97 26.12 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.345 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 47.51 42.61 14.89 Favored 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.619 0.723 . . . . 0.0 109.4 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.3 p80 38.97 37.87 0.25 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 113.773 -1.558 . . . . 0.0 114.649 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -49.02 98.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.205 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m -168.3 39.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 112.742 -2.026 . . . . 0.0 105.722 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.43 -29.12 0.02 OUTLIER Glycine 0 N--CA 1.494 2.561 0 CA-C-N 113.178 -1.828 . . . . 0.0 108.549 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -102.24 51.89 0.81 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.21 148.29 8.2 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 113.228 -1.805 . . . . 0.0 109.714 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 p -61.24 152.39 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.612 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 45.1 39.51 3.96 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.397 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.445 ' HD1' HE21 ' A' ' 15' ' ' GLN . 0.5 OUTLIER -56.97 85.03 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 113.273 -1.785 . . . . 0.0 111.429 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.445 HE21 ' HD1' ' A' ' 14' ' ' HIS . 7.7 mp0 -144.74 72.24 1.33 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.297 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.53 14.9 1.3 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.763 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 pp -49.28 -40.63 35.3 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.4 m -60.44 -54.44 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.709 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -57.98 -44.93 87.4 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.477 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -46.95 -17.73 0.06 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 114.563 -1.198 . . . . 0.0 113.977 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -123.22 -44.18 2.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 123.799 0.687 . . . . 0.0 111.117 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -71.91 -51.92 19.79 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.766 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.29 -41.28 94.3 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.889 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.9 m -63.31 -36.39 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.05 -49.33 76.15 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.9 p -82.05 32.49 0.38 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 123.943 0.437 . . . . 0.0 112.045 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -58.79 161.81 4.53 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.983 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -165.26 40.57 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.576 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 56.35 22.22 36.67 Favored Glycine 0 N--CA 1.494 2.565 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.714 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.9 -45.3 0.73 Allowed 'General case' 0 N--CA 1.484 1.251 0 O-C-N 124.592 0.819 . . . . 0.0 108.997 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.3 mm -53.31 -31.65 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 123.8 0.687 . . . . 0.0 111.148 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.1 mm -51.72 -55.6 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 124.652 1.22 . . . . 0.0 110.432 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.53 -39.36 25.92 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 60.17 44.31 12.97 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 122.686 1.231 . . . . 0.0 109.205 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.8 p -56.76 -35.96 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 124.092 0.87 . . . . 0.0 111.582 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.53 51.92 2.42 Favored Glycine 0 N--CA 1.494 2.512 0 CA-C-N 113.878 -1.51 . . . . 0.0 109.392 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.48 43.65 0.26 Allowed Glycine 0 N--CA 1.487 2.036 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.9 p -89.96 27.68 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.288 1.042 . . . . 0.0 110.081 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.5 p . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 116.182 -1.866 . . . . 0.0 111.685 -179.968 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 29.9 t70 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.7 39.32 17.37 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-N 114.992 -1.004 . . . . 0.0 112.204 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.69 66.58 4.44 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.004 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -73.23 146.86 45.17 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.256 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -83.9 -118.8 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.38 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.8 t60 18.35 64.78 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 125.521 1.763 . . . . 0.0 113.163 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.3 94.42 0.11 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 112.979 -1.919 . . . . 0.0 112.057 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.8 m -115.42 123.27 48.21 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.48 41.47 99.26 Favored Glycine 0 N--CA 1.501 2.974 0 N-CA-C 107.814 -2.114 . . . . 0.0 107.814 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -99.78 57.36 1.0 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -161.11 -68.09 0.06 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 113.958 -1.474 . . . . 0.0 111.869 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 t -135.34 158.11 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 123.827 0.705 . . . . 0.0 109.963 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -132.78 47.47 2.51 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.011 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -87.11 37.6 0.77 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.369 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -135.88 -86.4 0.35 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.89 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -52.71 -17.64 1.42 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.35 -34.56 10.88 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 123.781 0.676 . . . . 0.0 110.569 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.474 ' CG2' ' H ' ' A' ' 19' ' ' PHE . 35.5 m -58.71 -60.87 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.018 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.474 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 24.0 m-85 -56.72 -40.75 76.23 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.521 0.677 . . . . 0.0 110.318 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -45.88 -23.29 0.27 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.297 -1.32 . . . . 0.0 114.097 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.07 -39.72 2.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 123.753 0.658 . . . . 0.0 110.571 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -73.37 -53.5 10.6 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.106 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.19 -36.07 82.86 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.1 m -61.75 -38.94 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.57 -54.13 36.31 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.579 -2.208 . . . . 0.0 107.579 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.6 m -94.21 52.64 1.62 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -51.02 148.66 4.13 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 114.482 -1.236 . . . . 0.0 112.415 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -165.95 42.05 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.291 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.76 45.8 0.07 OUTLIER Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.51 -46.53 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 114.977 -0.612 . . . . 0.0 109.53 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.4 mp -43.43 -31.51 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.0 tt -51.74 -27.3 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.61 -0.86 0.08 OUTLIER Glycine 0 N--CA 1.499 2.845 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.912 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 34.36 35.04 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.1 p -62.31 -41.19 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.026 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -162.5 -39.29 0.02 OUTLIER Glycine 0 N--CA 1.493 2.439 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.902 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.38 41.01 92.94 Favored Glycine 0 N--CA 1.493 2.498 0 O-C-N 124.139 0.552 . . . . 0.0 111.771 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 t -97.99 33.82 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 122.126 0.965 . . . . 0.0 108.809 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.493 1.696 0 CA-C-N 113.788 -1.551 . . . . 0.0 111.912 179.864 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.663 0.744 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.72 66.79 0.26 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.129 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 35.33 78.93 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 113.889 -1.505 . . . . 0.0 114.23 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -57.85 145.96 33.48 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.908 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 50.0 61.49 3.15 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 124.281 0.988 . . . . 0.0 110.387 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -83.0 57.9 4.13 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.087 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -58.43 149.96 23.67 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.628 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.434 ' HG ' ' N ' ' A' ' 12' ' ' VAL . 8.2 t 67.14 124.02 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 124.782 1.302 . . . . 0.0 111.21 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.26 -58.57 7.13 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -147.86 -11.97 0.38 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.614 0.721 . . . . 0.0 109.828 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -78.33 20.02 0.43 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.864 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.472 ' CG2' ' H ' ' A' ' 13' ' ' HIS . 7.1 p -68.65 -178.25 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-O 121.267 0.556 . . . . 0.0 111.105 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.472 ' H ' ' CG2' ' A' ' 12' ' ' VAL . 2.6 t-160 -106.97 47.29 0.89 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.878 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -47.53 91.26 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 112.878 -1.965 . . . . 0.0 110.596 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -179.57 -47.64 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -63.6 -12.17 31.01 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 113.708 -1.587 . . . . 0.0 110.717 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 pp -46.72 -33.58 4.44 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.895 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.436 ' CG2' ' H ' ' A' ' 19' ' ' PHE . 34.0 m -62.19 -57.03 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 O-C-N 123.877 0.735 . . . . 0.0 109.53 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.436 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 31.2 m-85 -59.46 -41.92 90.79 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.342 0.591 . . . . 0.0 110.319 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -48.57 -16.06 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 114.317 -1.31 . . . . 0.0 114.138 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -125.85 -43.78 1.83 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 123.738 0.649 . . . . 0.0 110.655 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -73.17 -53.68 10.37 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.773 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.24 -40.19 93.71 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 117.924 -1.036 . . . . 0.0 112.191 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.2 m -60.01 -37.33 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.92 -51.41 59.34 Favored Glycine 0 N--CA 1.489 2.171 0 CA-C-N 113.097 -1.865 . . . . 0.0 109.064 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.0 m -59.91 -50.44 73.77 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 124.629 0.841 . . . . 0.0 111.212 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -74.45 -170.92 1.09 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 114.242 -1.344 . . . . 0.0 110.848 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 tttt 54.47 67.0 1.08 Allowed 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 122.436 1.112 . . . . 0.0 108.521 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.89 24.63 3.2 Favored Glycine 0 N--CA 1.497 2.71 0 CA-C-N 112.676 -2.056 . . . . 0.0 112.807 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.89 36.56 21.99 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.6 mt -40.65 -30.39 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -46.01 -31.4 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 124.202 0.939 . . . . 0.0 112.235 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -141.89 46.08 0.9 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.8 tp -165.5 101.56 0.71 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.2 t -64.0 -24.76 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.859 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.06 29.89 9.32 Favored Glycine 0 N--CA 1.497 2.73 0 O-C-N 123.955 0.784 . . . . 0.0 111.309 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.06 41.0 97.82 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 124.06 0.506 . . . . 0.0 112.229 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.3 t -110.75 41.99 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.498 1.971 0 CA-C-O 114.974 -2.441 . . . . 0.0 111.163 179.941 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.0 105.85 0.2 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 123.855 0.722 . . . . 0.0 109.614 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.51 65.41 7.86 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -73.86 179.12 4.44 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 114.017 -1.447 . . . . 0.0 113.733 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.68 53.18 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -80.93 26.4 0.42 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.205 -1.362 . . . . 0.0 113.392 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -66.3 149.05 50.94 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 113.357 -1.747 . . . . 0.0 111.988 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.505 ' HG ' ' HD1' ' A' ' 13' ' ' HIS . 3.4 m 51.58 43.51 29.71 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 122.408 1.099 . . . . 0.0 109.615 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -147.73 -64.69 0.01 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 107.342 -2.303 . . . . 0.0 107.342 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -137.08 12.13 3.07 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -159.32 171.19 20.26 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.533 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 p -59.74 173.88 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 124.355 1.034 . . . . 0.0 112.102 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.505 ' HD1' ' HG ' ' A' ' 8' ' ' SER . 8.4 t-160 -141.36 55.87 1.53 Allowed 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.915 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -58.78 133.78 56.27 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 113.578 -1.646 . . . . 0.0 110.407 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.426 HE21 ' NZ ' ' A' ' 16' ' ' LYS . 6.7 tt0 -91.63 -118.82 0.07 Allowed 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.426 ' NZ ' HE21 ' A' ' 15' ' ' GLN . 38.1 mmtm -54.03 -25.73 22.87 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.721 0.772 . . . . 0.0 111.014 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.7 tt -52.5 -25.96 11.72 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.107 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.403 ' CG2' ' H ' ' A' ' 19' ' ' PHE . 33.3 m -65.77 -53.98 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.403 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 27.8 m-85 -59.11 -41.6 88.55 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.715 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -46.45 -19.17 0.07 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 114.19 -1.368 . . . . 0.0 113.589 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -127.46 -40.53 1.78 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 123.566 0.541 . . . . 0.0 111.067 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -75.21 -49.58 18.92 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.532 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.16 -39.75 86.55 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.939 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.3 m -61.36 -37.43 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.79 -45.74 95.1 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.8 m -82.69 31.56 0.42 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.042 -0.579 . . . . 0.0 111.156 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -58.9 167.26 1.65 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? 57.93 64.95 1.4 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 122.721 1.248 . . . . 0.0 108.904 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 43.88 33.48 2.59 Favored Glycine 0 N--CA 1.498 2.788 0 CA-C-N 112.162 -2.29 . . . . 0.0 113.658 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.2 21.18 2.11 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.3 mm -51.12 -31.8 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 120.636 0.255 . . . . 0.0 111.17 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.9 tt -47.44 -26.89 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 124.58 1.175 . . . . 0.0 113.521 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.74 54.59 0.43 Allowed Glycine 0 N--CA 1.494 2.537 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.39 41.01 0.59 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 114.876 -0.662 . . . . 0.0 112.737 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.406 ' CG1' ' N ' ' A' ' 37' ' ' GLY . 9.2 p -67.71 -51.26 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 123.901 0.751 . . . . 0.0 111.973 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.406 ' N ' ' CG1' ' A' ' 36' ' ' VAL . . . 119.77 58.01 0.25 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.51 65.11 2.69 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.7 p 43.68 30.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 125.306 1.239 . . . . 0.0 112.638 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.1 t . . . . . 0 N--CA 1.489 1.521 0 CA-C-N 112.808 -1.996 . . . . 0.0 107.477 -179.923 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.51 97.57 0.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.152 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -136.44 87.12 2.27 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.166 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -65.01 122.18 16.41 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.373 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -145.46 76.46 1.48 Allowed 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.922 0.868 . . . . 0.0 109.332 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -82.89 40.16 0.67 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 113.969 -1.469 . . . . 0.0 111.386 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.416 ' CG ' ' H ' ' A' ' 8' ' ' SER . 28.8 t0 57.45 -166.79 0.14 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.946 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.416 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 7.4 p 56.21 -166.28 0.12 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 66.94 -99.57 0.5 Allowed Glycine 0 N--CA 1.498 2.773 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -107.14 44.4 1.07 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.2 167.73 25.52 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 113.221 -1.809 . . . . 0.0 110.204 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.0 t -57.7 164.43 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.387 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.403 ' C ' ' H ' ' A' ' 15' ' ' GLN . 17.8 t-80 -103.51 35.63 2.54 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.549 0.69 . . . . 0.0 109.98 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.3 42.05 0.92 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.831 1.3 . . . . 0.0 109.652 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.403 ' H ' ' C ' ' A' ' 13' ' ' HIS . 14.9 mt-30 -55.7 -17.55 6.15 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.25 -1.796 . . . . 0.0 112.031 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -71.97 -71.46 0.28 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.761 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.1 pp -51.65 -41.02 61.03 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.405 ' CG2' ' H ' ' A' ' 19' ' ' PHE . 26.7 m -58.67 -60.9 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.355 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.405 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 19.6 m-30 -61.01 -37.3 82.06 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -47.39 -19.9 0.19 Allowed 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -120.21 -43.76 2.52 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 123.902 0.751 . . . . 0.0 109.259 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -69.19 -57.52 5.26 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.575 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.92 -36.63 81.93 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.0 m -63.81 -38.72 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.92 -51.04 61.05 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 107.451 -2.26 . . . . 0.0 107.451 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.9 t -90.23 43.28 1.14 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 124.348 0.675 . . . . 0.0 109.4 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -56.58 157.13 5.49 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.65 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.4 mttt 56.28 20.72 4.79 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.323 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.4 23.32 28.8 Favored Glycine 0 N--CA 1.489 2.228 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.454 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -171.42 -58.81 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 mp -53.04 -31.06 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.53 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.0 tt -52.32 -24.29 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-N 114.532 -1.213 . . . . 0.0 113.452 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -121.51 -46.03 0.33 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.1 tp 33.54 48.49 0.19 Allowed 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 p -59.57 -30.89 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.463 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.48 23.66 10.06 Favored Glycine 0 N--CA 1.497 2.715 0 CA-C-N 113.991 -1.459 . . . . 0.0 111.326 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 53.9 37.23 57.39 Favored Glycine 0 N--CA 1.495 2.611 0 O-C-N 124.141 0.554 . . . . 0.0 111.876 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.0 p -93.23 29.18 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 122.178 0.99 . . . . 0.0 110.356 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 116.4 -1.762 . . . . 0.0 110.368 -179.959 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.5 t70 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.42 59.72 4.92 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.209 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 50.95 35.49 12.72 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.833 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -130.03 -161.84 1.15 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.141 -1.39 . . . . 0.0 110.058 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.9 ttt85 54.22 88.73 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 124.033 0.833 . . . . 0.0 112.77 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -86.29 38.58 0.78 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.799 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.07 128.54 34.21 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.299 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 p -170.94 142.99 1.95 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.355 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.7 163.95 34.41 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -145.37 -40.3 0.24 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.562 0.696 . . . . 0.0 109.624 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -58.01 126.2 26.42 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 113.528 -1.669 . . . . 0.0 110.145 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.459 ' CG2' ' H ' ' A' ' 13' ' ' HIS . 6.4 p 43.46 -151.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 123.707 0.629 . . . . 0.0 111.799 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.459 ' H ' ' CG2' ' A' ' 12' ' ' VAL . 0.6 OUTLIER -117.33 42.13 2.63 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.374 0.607 . . . . 0.0 110.181 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.51 63.46 1.09 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.355 -1.293 . . . . 0.0 112.276 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -169.55 -77.51 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -52.58 -26.04 12.26 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 tt -44.53 -32.16 1.33 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 123.892 0.745 . . . . 0.0 112.5 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.506 ' CG2' ' H ' ' A' ' 19' ' ' PHE . 31.8 m -66.53 -59.6 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.75 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.506 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 32.5 m-85 -57.23 -38.14 73.34 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.164 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -39.11 -31.37 0.07 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.176 -1.375 . . . . 0.0 112.828 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.33 -49.23 2.05 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 124.546 1.154 . . . . 0.0 109.925 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -58.95 -47.39 85.25 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.46 -0.496 . . . . 0.0 112.209 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.47 -38.68 90.78 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 118.964 -1.095 . . . . 0.0 111.846 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -55.49 -47.62 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.48 -49.72 67.39 Favored Glycine 0 N--CA 1.489 2.184 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.931 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.5 m -53.47 -51.25 63.32 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.308 0.575 . . . . 0.0 110.549 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -62.28 166.37 5.03 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.874 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -126.47 43.98 2.98 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.237 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -173.91 -41.31 0.04 OUTLIER Glycine 0 N--CA 1.487 2.097 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.974 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -48.24 -33.62 8.95 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.459 ' CD1' ' H ' ' A' ' 31' ' ' ILE . 3.1 mp -58.81 -67.09 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.598 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.1 tt -61.01 -37.63 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 123.489 0.493 . . . . 0.0 111.375 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.73 13.05 7.19 Favored Glycine 0 N--CA 1.495 2.611 0 O-C-N 123.75 0.657 . . . . 0.0 112.826 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.17 96.98 1.75 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.7 p -55.08 -42.27 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.836 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 172.37 -20.22 0.06 OUTLIER Glycine 0 N--CA 1.493 2.454 0 CA-C-N 113.186 -1.825 . . . . 0.0 109.467 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.79 33.53 0.22 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.5 p 38.09 45.67 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 CA-C-O 122.79 1.281 . . . . 0.0 112.356 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.497 1.912 0 CA-C-N 112.702 -2.045 . . . . 0.0 113.377 -179.993 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.5 t70 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 47.66 79.38 0.06 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 124.694 1.246 . . . . 0.0 112.216 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 51.98 29.33 6.07 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.862 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.21 -170.57 3.17 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.13 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.6 ttp85 -152.57 37.1 0.52 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.17 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -86.75 52.19 2.44 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.879 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -71.5 88.68 0.93 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.634 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 t 60.75 -176.95 0.11 Allowed 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.308 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.59 -30.98 63.42 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -155.51 123.29 5.68 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.99 85.41 0.15 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 124.154 0.909 . . . . 0.0 109.811 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 p -70.37 151.66 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.472 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 43.09 37.58 1.23 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.383 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -59.13 113.23 2.02 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 113.093 -1.867 . . . . 0.0 112.1 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -166.59 -57.69 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.96 -21.98 9.28 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 114.292 -1.322 . . . . 0.0 112.165 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 pp -48.03 -32.56 6.78 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.725 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.446 ' CG2' ' H ' ' A' ' 19' ' ' PHE . 33.6 m -62.33 -57.81 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 123.696 0.623 . . . . 0.0 109.663 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.446 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 32.1 m-85 -60.32 -42.94 96.66 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.419 0.628 . . . . 0.0 110.738 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -50.64 -13.33 0.13 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -126.81 -42.67 1.75 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 123.483 0.489 . . . . 0.0 110.806 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -77.16 -51.85 10.27 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.379 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.71 -40.41 96.71 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 117.963 -1.017 . . . . 0.0 112.543 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.6 m -57.25 -36.75 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.89 -50.42 52.97 Favored Glycine 0 N--CA 1.487 2.035 0 CA-C-N 112.946 -1.934 . . . . 0.0 108.763 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.9 m -52.13 -55.89 17.99 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 124.24 0.612 . . . . 0.0 112.051 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -83.34 -176.17 6.19 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.304 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.4 mttm 53.52 31.19 11.9 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 122.655 1.217 . . . . 0.0 111.253 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 174.81 29.56 0.03 OUTLIER Glycine 0 N--CA 1.485 1.947 0 CA-C-N 112.512 -2.131 . . . . 0.0 110.124 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -166.49 -21.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.915 -0.642 . . . . 0.0 110.192 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.9 mm -40.94 -32.01 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.0 tt -48.22 -30.56 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.99 -28.66 0.71 Allowed Glycine 0 N--CA 1.495 2.583 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 tt 59.33 72.7 0.51 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.378 1.085 . . . . 0.0 110.794 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 t -84.94 6.72 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-N 113.794 -1.548 . . . . 0.0 110.708 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 58.35 18.75 37.39 Favored Glycine 0 N--CA 1.498 2.819 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.344 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.13 36.82 76.58 Favored Glycine 0 N--CA 1.491 2.351 0 O-C-N 124.053 0.501 . . . . 0.0 112.01 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -89.23 30.18 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.953 0.882 . . . . 0.0 110.166 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.4 t . . . . . 0 N--CA 1.492 1.639 0 CA-C-N 113.645 -1.616 . . . . 0.0 109.363 179.892 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 120.978 0.418 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.38 60.07 3.96 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.005 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 52.94 26.3 4.59 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.878 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -41.33 136.8 1.59 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.96 76.34 10.05 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 39.81 37.53 0.36 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 112.738 -2.028 . . . . 0.0 113.746 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -165.71 118.08 1.12 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 113.489 -1.687 . . . . 0.0 109.793 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.3 p -173.92 118.84 0.26 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 124.242 0.964 . . . . 0.0 109.239 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.71 111.3 0.14 Allowed Glycine 0 N--CA 1.495 2.615 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.341 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -119.53 71.01 0.86 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -167.44 -28.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 113.499 -1.682 . . . . 0.0 109.974 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 p -61.74 161.71 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.622 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -99.69 40.22 1.25 Allowed 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.328 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.53 80.89 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 113.659 -1.61 . . . . 0.0 112.561 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -49.77 -23.63 1.93 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -49.32 -25.34 2.34 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.523 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -46.86 -30.55 2.55 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.225 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.451 ' CG2' ' H ' ' A' ' 19' ' ' PHE . 34.1 m -63.86 -58.01 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.451 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 25.6 m-85 -58.29 -40.28 81.52 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.125 0.488 . . . . 0.0 110.867 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -45.2 -23.83 0.21 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 114.774 -1.103 . . . . 0.0 113.622 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.08 -40.52 2.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 123.734 0.646 . . . . 0.0 111.09 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -71.51 -51.13 25.28 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.929 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -62.14 -44.74 95.95 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.705 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.7 m -57.22 -35.05 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 118.901 -1.12 . . . . 0.0 107.981 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.89 -45.28 64.54 Favored Glycine 0 CA--C 1.544 1.901 0 CA-C-N 112.837 -1.983 . . . . 0.0 110.862 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.9 p -67.9 -46.03 72.75 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -71.76 161.26 31.23 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.97 40.26 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 113.882 -1.508 . . . . 0.0 108.948 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.49 54.4 0.3 Allowed Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.83 -68.01 0.19 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 23.3 mm -50.49 -25.57 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.248 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.8 tt -53.23 -25.2 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 115.117 -0.947 . . . . 0.0 113.471 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -139.42 -29.69 0.21 Allowed Glycine 0 N--CA 1.497 2.755 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 53.41 81.28 0.09 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.437 0.637 . . . . 0.0 111.252 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.6 t -61.48 -25.2 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.562 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.75 -46.85 0.64 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 176.27 34.22 0.05 OUTLIER Glycine 0 N--CA 1.485 1.965 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 t -97.28 26.45 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 122.119 0.961 . . . . 0.0 108.989 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 116.207 -1.854 . . . . 0.0 108.917 -179.939 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.37 48.51 21.09 Favored 'General case' 0 N--CA 1.502 2.135 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.938 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 45.29 80.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.726 -1.579 . . . . 0.0 110.732 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -92.97 142.91 26.77 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.353 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.36 62.04 7.19 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 124.015 0.822 . . . . 0.0 111.187 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.8 p80 27.09 45.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -164.36 143.41 7.37 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.242 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.0 t -60.18 129.33 41.17 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.015 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.43 6.2 83.56 Favored Glycine 0 N--CA 1.494 2.531 0 CA-C-N 115.028 -0.987 . . . . 0.0 113.118 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.24 62.71 2.15 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -168.78 -2.55 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 111.122 -2.763 . . . . 0.0 109.47 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.27 155.02 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 CA-C-O 121.329 0.585 . . . . 0.0 111.492 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 41.58 36.21 0.55 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 113.074 -1.875 . . . . 0.0 111.653 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.519 ' HD1' ' H ' ' A' ' 14' ' ' HIS . 14.4 p-80 -72.76 107.46 5.21 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.618 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -51.68 -19.42 1.58 Allowed 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.746 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -48.0 -23.72 0.88 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.214 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.3 mt -42.58 -33.52 0.71 Allowed 'General case' 0 N--CA 1.5 2.054 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.895 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.471 ' CG2' ' H ' ' A' ' 19' ' ' PHE . 34.4 m -63.5 -59.83 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.471 ' H ' ' CG2' ' A' ' 18' ' ' VAL . 25.8 m-85 -56.65 -37.44 70.79 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.507 0.67 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -42.59 -26.29 0.12 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 113.865 -1.516 . . . . 0.0 113.158 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -124.3 -42.71 2.1 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 124.167 0.917 . . . . 0.0 110.077 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -67.22 -50.85 59.19 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.275 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -61.37 -33.76 74.18 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.697 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.445 HG21 ' N ' ' A' ' 25' ' ' GLY . 2.9 m -54.76 -42.01 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.445 ' N ' HG21 ' A' ' 24' ' ' VAL . . . -69.55 -49.26 38.6 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.3 t -79.99 24.74 0.4 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 -70.1 168.25 15.98 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.213 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.2 pttm -179.79 33.72 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 113.747 -1.57 . . . . 0.0 109.426 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.14 39.88 0.03 OUTLIER Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.001 -1.639 . . . . 0.0 109.001 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.11 -58.39 0.38 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 54.6 mt -61.51 -56.09 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.8 tt -65.05 -30.14 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 114.146 -1.388 . . . . 0.0 108.675 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.88 18.14 27.97 Favored Glycine 0 N--CA 1.494 2.515 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.169 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.6 tp -156.91 82.57 0.94 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.2 t -69.4 -54.71 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.226 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.17 36.26 63.95 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.14 54.57 0.18 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 t -124.28 45.25 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.4 t . . . . . 0 N--CA 1.499 2.016 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.971 179.965 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 110.586 -0.153 . . . . 0.0 110.586 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.1 tp -41.29 -49.82 3.69 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.709 HG23 ' H ' ' A' ' 19' ' ' PHE . 31.0 m -51.81 -60.83 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 124.045 0.841 . . . . 0.0 110.923 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.709 ' H ' HG23 ' A' ' 18' ' ' VAL . 32.2 m-85 -60.19 -44.92 94.7 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.702 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -49.6 -8.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 124.974 1.421 . . . . 0.0 113.752 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 24' ' ' VAL . . . -118.23 -53.52 2.35 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -54.89 -38.29 67.38 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.07 -37.96 78.78 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.443 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.427 ' H ' HG13 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -61.92 -47.58 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 105.21 -2.145 . . . . 0.0 105.21 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.77 -46.68 93.65 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.486 1.367 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.916 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.402 ' HG3' ' HB2' ' A' ' 19' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 pp -49.28 -40.63 35.3 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.525 HG23 ' CD2' ' A' ' 19' ' ' PHE . 34.4 m -60.44 -54.44 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.709 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.525 ' CD2' HG23 ' A' ' 18' ' ' VAL . 77.8 m-85 -57.98 -44.93 87.4 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.477 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -46.95 -17.73 0.06 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 114.563 -1.198 . . . . 0.0 113.977 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -123.22 -44.18 2.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 123.799 0.687 . . . . 0.0 111.117 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -71.91 -51.92 19.79 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.766 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.29 -41.28 94.3 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.889 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.9 m -63.31 -36.39 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.05 -49.33 76.15 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.9 p . . . . . 0 N--CA 1.49 1.54 0 O-C-N 123.943 0.437 . . . . 0.0 112.045 179.891 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? . . . . . 0 N--CA 1.497 1.886 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.35 -34.56 10.88 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 123.781 0.676 . . . . 0.0 110.569 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.65 HG23 ' H ' ' A' ' 19' ' ' PHE . 35.5 m -58.71 -60.87 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.018 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.65 ' H ' HG23 ' A' ' 18' ' ' VAL . 24.0 m-85 -56.72 -40.75 76.23 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.521 0.677 . . . . 0.0 110.318 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -45.88 -23.29 0.27 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.297 -1.32 . . . . 0.0 114.097 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.07 -39.72 2.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 123.753 0.658 . . . . 0.0 110.571 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -73.37 -53.5 10.6 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.106 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.19 -36.07 82.86 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.1 m -61.75 -38.94 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.57 -54.13 36.31 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.579 -2.208 . . . . 0.0 107.579 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.858 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.635 0.255 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 pp -46.72 -33.58 4.44 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.895 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.543 HG23 ' N ' ' A' ' 19' ' ' PHE . 34.0 m -62.19 -57.03 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 O-C-N 123.877 0.735 . . . . 0.0 109.53 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.543 ' N ' HG23 ' A' ' 18' ' ' VAL . 31.2 m-85 -59.46 -41.92 90.79 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.342 0.591 . . . . 0.0 110.319 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -48.57 -16.06 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 114.317 -1.31 . . . . 0.0 114.138 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -125.85 -43.78 1.83 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 123.738 0.649 . . . . 0.0 110.655 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -73.17 -53.68 10.37 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.773 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.24 -40.19 93.71 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 117.924 -1.036 . . . . 0.0 112.191 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.2 m -60.01 -37.33 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.92 -51.41 59.34 Favored Glycine 0 N--CA 1.489 2.171 0 CA-C-N 113.097 -1.865 . . . . 0.0 109.064 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.497 1.879 0 O-C-N 124.629 0.841 . . . . 0.0 111.212 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 121.721 0.772 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.478 HD23 ' O ' ' A' ' 17' ' ' LEU . 4.7 tt -52.5 -25.96 11.72 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.107 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.541 HG23 ' N ' ' A' ' 19' ' ' PHE . 33.3 m -65.77 -53.98 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.541 ' N ' HG23 ' A' ' 18' ' ' VAL . 27.8 m-85 -59.11 -41.6 88.55 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.715 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -46.45 -19.17 0.07 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 114.19 -1.368 . . . . 0.0 113.589 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -127.46 -40.53 1.78 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 123.566 0.541 . . . . 0.0 111.067 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -75.21 -49.58 18.92 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.532 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.16 -39.75 86.55 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.939 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.3 m -61.36 -37.43 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.79 -45.74 95.1 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.8 m . . . . . 0 N--CA 1.489 1.522 0 CA-C-N 115.042 -0.579 . . . . 0.0 111.156 179.776 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.1 pp -51.65 -41.02 61.03 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.639 HG23 ' H ' ' A' ' 19' ' ' PHE . 26.7 m -58.67 -60.9 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.355 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.639 ' H ' HG23 ' A' ' 18' ' ' VAL . 19.6 m-30 -61.01 -37.3 82.06 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -47.39 -19.9 0.19 Allowed 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -120.21 -43.76 2.52 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 123.902 0.751 . . . . 0.0 109.259 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -69.19 -57.52 5.26 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.575 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.92 -36.63 81.93 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.0 m -63.81 -38.72 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.92 -51.04 61.05 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 107.451 -2.26 . . . . 0.0 107.451 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.487 1.38 0 O-C-N 124.348 0.675 . . . . 0.0 109.4 179.852 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 tt -44.53 -32.16 1.33 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 123.892 0.745 . . . . 0.0 112.5 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.621 HG23 ' H ' ' A' ' 19' ' ' PHE . 31.8 m -66.53 -59.6 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.75 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.621 ' H ' HG23 ' A' ' 18' ' ' VAL . 32.5 m-85 -57.23 -38.14 73.34 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.164 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -39.11 -31.37 0.07 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.176 -1.375 . . . . 0.0 112.828 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.33 -49.23 2.05 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 124.546 1.154 . . . . 0.0 109.925 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -58.95 -47.39 85.25 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.46 -0.496 . . . . 0.0 112.209 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.47 -38.68 90.78 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 118.964 -1.095 . . . . 0.0 111.846 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -55.49 -47.62 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.48 -49.72 67.39 Favored Glycine 0 N--CA 1.489 2.184 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.931 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.499 1.984 0 CA-C-O 121.308 0.575 . . . . 0.0 110.549 179.895 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 pp -48.03 -32.56 6.78 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.725 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.545 HG23 ' H ' ' A' ' 19' ' ' PHE . 33.6 m -62.33 -57.81 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 123.696 0.623 . . . . 0.0 109.663 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.545 ' H ' HG23 ' A' ' 18' ' ' VAL . 32.1 m-85 -60.32 -42.94 96.66 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.419 0.628 . . . . 0.0 110.738 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -50.64 -13.33 0.13 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -126.81 -42.67 1.75 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 123.483 0.489 . . . . 0.0 110.806 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -77.16 -51.85 10.27 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.379 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.71 -40.41 96.71 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 117.963 -1.017 . . . . 0.0 112.543 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.6 m -57.25 -36.75 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.89 -50.42 52.97 Favored Glycine 0 N--CA 1.487 2.035 0 CA-C-N 112.946 -1.934 . . . . 0.0 108.763 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.9 m . . . . . 0 N--CA 1.497 1.902 0 O-C-N 124.24 0.612 . . . . 0.0 112.051 179.973 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -46.86 -30.55 2.55 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.225 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.555 HG23 ' H ' ' A' ' 19' ' ' PHE . 34.1 m -63.86 -58.01 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.555 ' H ' HG23 ' A' ' 18' ' ' VAL . 25.6 m-85 -58.29 -40.28 81.52 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.125 0.488 . . . . 0.0 110.867 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -45.2 -23.83 0.21 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 114.774 -1.103 . . . . 0.0 113.622 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.08 -40.52 2.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 123.734 0.646 . . . . 0.0 111.09 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -71.51 -51.13 25.28 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.929 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -62.14 -44.74 95.95 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.705 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.7 m -57.22 -35.05 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 118.901 -1.12 . . . . 0.0 107.981 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.89 -45.28 64.54 Favored Glycine 0 CA--C 1.544 1.901 0 CA-C-N 112.837 -1.983 . . . . 0.0 110.862 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.9 p . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -179.787 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 120.549 0.214 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.3 mt -42.58 -33.52 0.71 Allowed 'General case' 0 N--CA 1.5 2.054 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.895 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.602 HG23 ' H ' ' A' ' 19' ' ' PHE . 34.4 m -63.5 -59.83 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.602 ' H ' HG23 ' A' ' 18' ' ' VAL . 25.8 m-85 -56.65 -37.44 70.79 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.507 0.67 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -42.59 -26.29 0.12 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 113.865 -1.516 . . . . 0.0 113.158 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.751 ' O ' HG22 ' A' ' 24' ' ' VAL . . . -124.3 -42.71 2.1 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 124.167 0.917 . . . . 0.0 110.077 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -67.22 -50.85 59.19 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.275 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -61.37 -33.76 74.18 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.697 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.751 HG22 ' O ' ' A' ' 21' ' ' ALA . 2.9 m -54.76 -42.01 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.55 -49.26 38.6 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 179.959 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 30.1 t70 . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.32 53.37 1.3 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 124.555 1.16 . . . . 0.0 111.159 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -89.12 38.87 0.91 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.495 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -64.7 148.71 50.52 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.022 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -137.17 43.64 2.34 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.645 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.6 33.09 0.36 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.806 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.37 124.73 21.7 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.52 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.0 m -65.85 -169.9 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.356 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.15 -57.82 0.78 Allowed Glycine 0 N--CA 1.497 2.748 0 N-CA-C 105.481 -3.047 . . . . 0.0 105.481 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -124.53 36.58 4.58 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -168.49 162.08 12.03 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 112.694 -2.048 . . . . 0.0 108.928 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -60.97 151.83 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.622 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -99.96 28.73 4.62 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.23 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -100.89 46.23 0.95 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.953 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.415 ' O ' HG22 ' A' ' 18' ' ' VAL . 6.2 mp0 -62.43 -4.52 1.92 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.832 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.68 -41.84 23.03 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.586 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.1 tp -41.29 -49.82 3.69 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.709 HG23 ' H ' ' A' ' 19' ' ' PHE . 31.0 m -51.81 -60.83 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 124.045 0.841 . . . . 0.0 110.923 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.709 ' H ' HG23 ' A' ' 18' ' ' VAL . 32.2 m-85 -60.19 -44.92 94.7 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.702 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -49.6 -8.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 124.974 1.421 . . . . 0.0 113.752 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 24' ' ' VAL . . . -118.23 -53.52 2.35 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -54.89 -38.29 67.38 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.07 -37.96 78.78 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.443 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.427 ' H ' HG13 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -61.92 -47.58 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 105.21 -2.145 . . . . 0.0 105.21 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.77 -46.68 93.65 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.1 t -92.29 40.22 1.04 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -48.65 150.05 1.52 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 114.953 -1.021 . . . . 0.0 113.102 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.74 43.09 0.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 113.76 -1.564 . . . . 0.0 107.046 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.46 20.8 18.19 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.16 20.69 3.5 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 124.542 0.79 . . . . 0.0 112.41 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 55.9 mt -55.27 -26.96 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.055 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.5 tt -50.25 -30.48 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 124.442 1.089 . . . . 0.0 111.854 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.33 -39.68 1.61 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 107.248 -2.341 . . . . 0.0 107.248 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 57.76 32.9 22.55 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 122.176 0.989 . . . . 0.0 111.083 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.2 p -60.09 -42.44 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.373 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.82 36.1 0.45 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.07 49.72 0.19 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.3 t -97.14 34.24 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 115.049 -2.405 . . . . 0.0 111.178 -179.999 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 t70 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 122.016 0.913 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -170.44 62.83 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -121.22 10.57 10.67 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 112.886 -1.961 . . . . 0.0 110.837 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -63.91 125.97 26.12 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.345 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 47.51 42.61 14.89 Favored 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.619 0.723 . . . . 0.0 109.4 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.3 p80 38.97 37.87 0.25 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 113.773 -1.558 . . . . 0.0 114.649 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -49.02 98.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.205 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m -168.3 39.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 112.742 -2.026 . . . . 0.0 105.722 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 10' ' ' TYR . . . -157.43 -29.12 0.02 OUTLIER Glycine 0 N--CA 1.494 2.561 0 CA-C-N 113.178 -1.828 . . . . 0.0 108.549 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.407 ' H ' ' H ' ' A' ' 9' ' ' GLY . 18.6 t80 -102.24 51.89 0.81 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.21 148.29 8.2 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 113.228 -1.805 . . . . 0.0 109.714 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 p -61.24 152.39 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.612 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 45.1 39.51 3.96 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.397 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -56.97 85.03 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 113.273 -1.785 . . . . 0.0 111.429 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -144.74 72.24 1.33 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.297 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.402 ' HG3' ' HB2' ' A' ' 19' ' ' PHE . 0.1 OUTLIER 55.53 14.9 1.3 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.763 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 pp -49.28 -40.63 35.3 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.525 HG23 ' CD2' ' A' ' 19' ' ' PHE . 34.4 m -60.44 -54.44 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.709 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.525 ' CD2' HG23 ' A' ' 18' ' ' VAL . 77.8 m-85 -57.98 -44.93 87.4 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.477 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -46.95 -17.73 0.06 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 114.563 -1.198 . . . . 0.0 113.977 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -123.22 -44.18 2.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 123.799 0.687 . . . . 0.0 111.117 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -71.91 -51.92 19.79 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.766 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.29 -41.28 94.3 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.889 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.9 m -63.31 -36.39 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.05 -49.33 76.15 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.9 p -82.05 32.49 0.38 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 123.943 0.437 . . . . 0.0 112.045 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -58.79 161.81 4.53 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.983 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -165.26 40.57 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.576 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 56.35 22.22 36.67 Favored Glycine 0 N--CA 1.494 2.565 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.714 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.9 -45.3 0.73 Allowed 'General case' 0 N--CA 1.484 1.251 0 O-C-N 124.592 0.819 . . . . 0.0 108.997 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.3 mm -53.31 -31.65 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 123.8 0.687 . . . . 0.0 111.148 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.1 mm -51.72 -55.6 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 124.652 1.22 . . . . 0.0 110.432 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.53 -39.36 25.92 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 60.17 44.31 12.97 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 122.686 1.231 . . . . 0.0 109.205 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.8 p -56.76 -35.96 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 124.092 0.87 . . . . 0.0 111.582 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.53 51.92 2.42 Favored Glycine 0 N--CA 1.494 2.512 0 CA-C-N 113.878 -1.51 . . . . 0.0 109.392 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.48 43.65 0.26 Allowed Glycine 0 N--CA 1.487 2.036 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.9 p -89.96 27.68 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.288 1.042 . . . . 0.0 110.081 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.5 p . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 116.182 -1.866 . . . . 0.0 111.685 -179.968 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 29.9 t70 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.7 39.32 17.37 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-N 114.992 -1.004 . . . . 0.0 112.204 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.69 66.58 4.44 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.004 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -73.23 146.86 45.17 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.256 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -83.9 -118.8 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.38 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 18.35 64.78 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 125.521 1.763 . . . . 0.0 113.163 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.3 94.42 0.11 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 112.979 -1.919 . . . . 0.0 112.057 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.8 m -115.42 123.27 48.21 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.48 41.47 99.26 Favored Glycine 0 N--CA 1.501 2.974 0 N-CA-C 107.814 -2.114 . . . . 0.0 107.814 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -99.78 57.36 1.0 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -161.11 -68.09 0.06 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 113.958 -1.474 . . . . 0.0 111.869 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 t -135.34 158.11 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 123.827 0.705 . . . . 0.0 109.963 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -132.78 47.47 2.51 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.011 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -87.11 37.6 0.77 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.369 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.495 ' O ' HG22 ' A' ' 18' ' ' VAL . 10.1 mt-30 -135.88 -86.4 0.35 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.89 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -52.71 -17.64 1.42 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.35 -34.56 10.88 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 123.781 0.676 . . . . 0.0 110.569 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.65 HG23 ' H ' ' A' ' 19' ' ' PHE . 35.5 m -58.71 -60.87 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.018 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.65 ' H ' HG23 ' A' ' 18' ' ' VAL . 24.0 m-85 -56.72 -40.75 76.23 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.521 0.677 . . . . 0.0 110.318 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -45.88 -23.29 0.27 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.297 -1.32 . . . . 0.0 114.097 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.07 -39.72 2.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 123.753 0.658 . . . . 0.0 110.571 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -73.37 -53.5 10.6 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.106 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.19 -36.07 82.86 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.1 m -61.75 -38.94 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.57 -54.13 36.31 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.579 -2.208 . . . . 0.0 107.579 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.6 m -94.21 52.64 1.62 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -51.02 148.66 4.13 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 114.482 -1.236 . . . . 0.0 112.415 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -165.95 42.05 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.291 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.76 45.8 0.07 OUTLIER Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.51 -46.53 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 114.977 -0.612 . . . . 0.0 109.53 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.4 mp -43.43 -31.51 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.0 tt -51.74 -27.3 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.61 -0.86 0.08 OUTLIER Glycine 0 N--CA 1.499 2.845 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.912 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 34.36 35.04 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.1 p -62.31 -41.19 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.026 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -162.5 -39.29 0.02 OUTLIER Glycine 0 N--CA 1.493 2.439 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.902 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.38 41.01 92.94 Favored Glycine 0 N--CA 1.493 2.498 0 O-C-N 124.139 0.552 . . . . 0.0 111.771 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 t -97.99 33.82 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 122.126 0.965 . . . . 0.0 108.809 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.493 1.696 0 CA-C-N 113.788 -1.551 . . . . 0.0 111.912 179.864 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.663 0.744 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.72 66.79 0.26 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.129 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 35.33 78.93 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 113.889 -1.505 . . . . 0.0 114.23 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -57.85 145.96 33.48 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.908 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 50.0 61.49 3.15 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 124.281 0.988 . . . . 0.0 110.387 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -83.0 57.9 4.13 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.087 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -58.43 149.96 23.67 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.628 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.2 t 67.14 124.02 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 124.782 1.302 . . . . 0.0 111.21 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.26 -58.57 7.13 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.412 ' H ' ' H ' ' A' ' 11' ' ' GLU . 27.8 t80 -147.86 -11.97 0.38 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.614 0.721 . . . . 0.0 109.828 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 4.6 mp0 -78.33 20.02 0.43 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.864 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.716 HG22 ' H ' ' A' ' 13' ' ' HIS . 7.1 p -68.65 -178.25 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-O 121.267 0.556 . . . . 0.0 111.105 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.716 ' H ' HG22 ' A' ' 12' ' ' VAL . 2.6 t-160 -106.97 47.29 0.89 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.878 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -47.53 91.26 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 112.878 -1.965 . . . . 0.0 110.596 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -179.57 -47.64 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -63.6 -12.17 31.01 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 113.708 -1.587 . . . . 0.0 110.717 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 pp -46.72 -33.58 4.44 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.895 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.543 HG23 ' N ' ' A' ' 19' ' ' PHE . 34.0 m -62.19 -57.03 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 O-C-N 123.877 0.735 . . . . 0.0 109.53 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.543 ' N ' HG23 ' A' ' 18' ' ' VAL . 31.2 m-85 -59.46 -41.92 90.79 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.342 0.591 . . . . 0.0 110.319 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -48.57 -16.06 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 114.317 -1.31 . . . . 0.0 114.138 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -125.85 -43.78 1.83 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 123.738 0.649 . . . . 0.0 110.655 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -73.17 -53.68 10.37 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.773 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.24 -40.19 93.71 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 117.924 -1.036 . . . . 0.0 112.191 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.2 m -60.01 -37.33 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.92 -51.41 59.34 Favored Glycine 0 N--CA 1.489 2.171 0 CA-C-N 113.097 -1.865 . . . . 0.0 109.064 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.0 m -59.91 -50.44 73.77 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 124.629 0.841 . . . . 0.0 111.212 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -74.45 -170.92 1.09 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 114.242 -1.344 . . . . 0.0 110.848 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HB3' HD12 ' A' ' 31' ' ' ILE . 5.9 tttt 54.47 67.0 1.08 Allowed 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 122.436 1.112 . . . . 0.0 108.521 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.89 24.63 3.2 Favored Glycine 0 N--CA 1.497 2.71 0 CA-C-N 112.676 -2.056 . . . . 0.0 112.807 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.89 36.56 21.99 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.469 HD12 ' HB3' ' A' ' 28' ' ' LYS . 29.6 mt -40.65 -30.39 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -46.01 -31.4 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 124.202 0.939 . . . . 0.0 112.235 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -141.89 46.08 0.9 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.8 tp -165.5 101.56 0.71 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.2 t -64.0 -24.76 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.859 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.06 29.89 9.32 Favored Glycine 0 N--CA 1.497 2.73 0 O-C-N 123.955 0.784 . . . . 0.0 111.309 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.06 41.0 97.82 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 124.06 0.506 . . . . 0.0 112.229 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.3 t -110.75 41.99 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.498 1.971 0 CA-C-O 114.974 -2.441 . . . . 0.0 111.163 179.941 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.0 105.85 0.2 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 123.855 0.722 . . . . 0.0 109.614 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.51 65.41 7.86 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -73.86 179.12 4.44 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 114.017 -1.447 . . . . 0.0 113.733 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.68 53.18 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -80.93 26.4 0.42 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.205 -1.362 . . . . 0.0 113.392 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -66.3 149.05 50.94 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 113.357 -1.747 . . . . 0.0 111.988 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 m 51.58 43.51 29.71 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 122.408 1.099 . . . . 0.0 109.615 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -147.73 -64.69 0.01 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 107.342 -2.303 . . . . 0.0 107.342 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -137.08 12.13 3.07 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -159.32 171.19 20.26 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.533 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.58 HG22 ' H ' ' A' ' 13' ' ' HIS . 5.1 p -59.74 173.88 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 124.355 1.034 . . . . 0.0 112.102 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.58 ' H ' HG22 ' A' ' 12' ' ' VAL . 8.4 t-160 -141.36 55.87 1.53 Allowed 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.915 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -58.78 133.78 56.27 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 113.578 -1.646 . . . . 0.0 110.407 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.593 ' O ' HG22 ' A' ' 18' ' ' VAL . 4.0 tt0 -91.63 -118.82 0.07 Allowed 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -54.03 -25.73 22.87 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.721 0.772 . . . . 0.0 111.014 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.478 HD23 ' O ' ' A' ' 17' ' ' LEU . 4.7 tt -52.5 -25.96 11.72 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.107 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 15' ' ' GLN . 33.3 m -65.77 -53.98 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.541 ' N ' HG23 ' A' ' 18' ' ' VAL . 27.8 m-85 -59.11 -41.6 88.55 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.715 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -46.45 -19.17 0.07 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 114.19 -1.368 . . . . 0.0 113.589 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -127.46 -40.53 1.78 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 123.566 0.541 . . . . 0.0 111.067 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -75.21 -49.58 18.92 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.532 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.16 -39.75 86.55 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.939 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.3 m -61.36 -37.43 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.79 -45.74 95.1 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.8 m -82.69 31.56 0.42 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.042 -0.579 . . . . 0.0 111.156 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -58.9 167.26 1.65 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? 57.93 64.95 1.4 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 122.721 1.248 . . . . 0.0 108.904 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 43.88 33.48 2.59 Favored Glycine 0 N--CA 1.498 2.788 0 CA-C-N 112.162 -2.29 . . . . 0.0 113.658 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.2 21.18 2.11 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.3 mm -51.12 -31.8 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 120.636 0.255 . . . . 0.0 111.17 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.9 tt -47.44 -26.89 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 124.58 1.175 . . . . 0.0 113.521 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.74 54.59 0.43 Allowed Glycine 0 N--CA 1.494 2.537 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.39 41.01 0.59 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 114.876 -0.662 . . . . 0.0 112.737 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.483 HG13 ' N ' ' A' ' 37' ' ' GLY . 9.2 p -67.71 -51.26 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 123.901 0.751 . . . . 0.0 111.973 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.483 ' N ' HG13 ' A' ' 36' ' ' VAL . . . 119.77 58.01 0.25 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.51 65.11 2.69 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.7 p 43.68 30.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 125.306 1.239 . . . . 0.0 112.638 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.422 ' C ' HG22 ' A' ' 36' ' ' VAL . 57.1 t . . . . . 0 N--CA 1.489 1.521 0 CA-C-N 112.808 -1.996 . . . . 0.0 107.477 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.51 97.57 0.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.152 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -136.44 87.12 2.27 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.166 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -65.01 122.18 16.41 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.373 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -145.46 76.46 1.48 Allowed 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.922 0.868 . . . . 0.0 109.332 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -82.89 40.16 0.67 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 113.969 -1.469 . . . . 0.0 111.386 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 8' ' ' SER . 28.8 t0 57.45 -166.79 0.14 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.946 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.41 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 7.4 p 56.21 -166.28 0.12 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 66.94 -99.57 0.5 Allowed Glycine 0 N--CA 1.498 2.773 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -107.14 44.4 1.07 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.2 167.73 25.52 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 113.221 -1.809 . . . . 0.0 110.204 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 13' ' ' HIS . 23.0 t -57.7 164.43 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.387 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.413 ' N ' HG12 ' A' ' 12' ' ' VAL . 17.8 t-80 -103.51 35.63 2.54 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.549 0.69 . . . . 0.0 109.98 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.3 42.05 0.92 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.831 1.3 . . . . 0.0 109.652 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -55.7 -17.55 6.15 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.25 -1.796 . . . . 0.0 112.031 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -71.97 -71.46 0.28 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.761 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.1 pp -51.65 -41.02 61.03 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.639 HG23 ' H ' ' A' ' 19' ' ' PHE . 26.7 m -58.67 -60.9 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.355 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.639 ' H ' HG23 ' A' ' 18' ' ' VAL . 19.6 m-30 -61.01 -37.3 82.06 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -47.39 -19.9 0.19 Allowed 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -120.21 -43.76 2.52 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 123.902 0.751 . . . . 0.0 109.259 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -69.19 -57.52 5.26 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.575 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.92 -36.63 81.93 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.0 m -63.81 -38.72 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.92 -51.04 61.05 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 107.451 -2.26 . . . . 0.0 107.451 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.9 t -90.23 43.28 1.14 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 124.348 0.675 . . . . 0.0 109.4 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -56.58 157.13 5.49 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.65 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.4 mttt 56.28 20.72 4.79 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.323 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.4 23.32 28.8 Favored Glycine 0 N--CA 1.489 2.228 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.454 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -171.42 -58.81 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.448 HD12 ' H ' ' A' ' 31' ' ' ILE . 2.1 mp -53.04 -31.06 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.53 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.0 tt -52.32 -24.29 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-N 114.532 -1.213 . . . . 0.0 113.452 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -121.51 -46.03 0.33 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.1 tp 33.54 48.49 0.19 Allowed 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 p -59.57 -30.89 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.463 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.48 23.66 10.06 Favored Glycine 0 N--CA 1.497 2.715 0 CA-C-N 113.991 -1.459 . . . . 0.0 111.326 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 53.9 37.23 57.39 Favored Glycine 0 N--CA 1.495 2.611 0 O-C-N 124.141 0.554 . . . . 0.0 111.876 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.0 p -93.23 29.18 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 122.178 0.99 . . . . 0.0 110.356 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 116.4 -1.762 . . . . 0.0 110.368 -179.959 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.5 t70 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.42 59.72 4.92 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.209 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 50.95 35.49 12.72 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.833 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -130.03 -161.84 1.15 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.141 -1.39 . . . . 0.0 110.058 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.9 ttt85 54.22 88.73 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 124.033 0.833 . . . . 0.0 112.77 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -86.29 38.58 0.78 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.799 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.07 128.54 34.21 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.299 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 p -170.94 142.99 1.95 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.355 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.7 163.95 34.41 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -145.37 -40.3 0.24 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.562 0.696 . . . . 0.0 109.624 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -58.01 126.2 26.42 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 113.528 -1.669 . . . . 0.0 110.145 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.751 HG22 ' H ' ' A' ' 13' ' ' HIS . 6.4 p 43.46 -151.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 123.707 0.629 . . . . 0.0 111.799 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.751 ' H ' HG22 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -117.33 42.13 2.63 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.374 0.607 . . . . 0.0 110.181 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.51 63.46 1.09 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.355 -1.293 . . . . 0.0 112.276 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.537 ' O ' HG22 ' A' ' 18' ' ' VAL . 30.5 tt0 -169.55 -77.51 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -52.58 -26.04 12.26 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 tt -44.53 -32.16 1.33 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 123.892 0.745 . . . . 0.0 112.5 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.621 HG23 ' H ' ' A' ' 19' ' ' PHE . 31.8 m -66.53 -59.6 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.75 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.621 ' H ' HG23 ' A' ' 18' ' ' VAL . 32.5 m-85 -57.23 -38.14 73.34 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.164 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -39.11 -31.37 0.07 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.176 -1.375 . . . . 0.0 112.828 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.33 -49.23 2.05 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 124.546 1.154 . . . . 0.0 109.925 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -58.95 -47.39 85.25 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.46 -0.496 . . . . 0.0 112.209 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.47 -38.68 90.78 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 118.964 -1.095 . . . . 0.0 111.846 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -55.49 -47.62 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.48 -49.72 67.39 Favored Glycine 0 N--CA 1.489 2.184 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.931 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.5 m -53.47 -51.25 63.32 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.308 0.575 . . . . 0.0 110.549 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -62.28 166.37 5.03 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.874 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -126.47 43.98 2.98 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.237 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -173.91 -41.31 0.04 OUTLIER Glycine 0 N--CA 1.487 2.097 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.974 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -48.24 -33.62 8.95 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.78 HD12 ' H ' ' A' ' 31' ' ' ILE . 3.1 mp -58.81 -67.09 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.598 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.1 tt -61.01 -37.63 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 123.489 0.493 . . . . 0.0 111.375 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.73 13.05 7.19 Favored Glycine 0 N--CA 1.495 2.611 0 O-C-N 123.75 0.657 . . . . 0.0 112.826 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -156.17 96.98 1.75 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.429 HG11 HG12 ' A' ' 40' ' ' VAL . 10.7 p -55.08 -42.27 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.836 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.42 ' N ' HG13 ' A' ' 36' ' ' VAL . . . 172.37 -20.22 0.06 OUTLIER Glycine 0 N--CA 1.493 2.454 0 CA-C-N 113.186 -1.825 . . . . 0.0 109.467 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.79 33.53 0.22 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.5 p 38.09 45.67 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 CA-C-O 122.79 1.281 . . . . 0.0 112.356 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.429 HG12 HG11 ' A' ' 36' ' ' VAL . 3.5 p . . . . . 0 N--CA 1.497 1.912 0 CA-C-N 112.702 -2.045 . . . . 0.0 113.377 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.5 t70 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 47.66 79.38 0.06 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 124.694 1.246 . . . . 0.0 112.216 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 51.98 29.33 6.07 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.862 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.21 -170.57 3.17 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.13 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.6 ttp85 -152.57 37.1 0.52 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.17 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -86.75 52.19 2.44 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.879 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -71.5 88.68 0.93 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.634 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 t 60.75 -176.95 0.11 Allowed 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.308 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.59 -30.98 63.42 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -155.51 123.29 5.68 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.99 85.41 0.15 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 124.154 0.909 . . . . 0.0 109.811 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 p -70.37 151.66 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.472 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 43.09 37.58 1.23 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.383 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -59.13 113.23 2.02 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 113.093 -1.867 . . . . 0.0 112.1 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.521 ' O ' HG22 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -166.59 -57.69 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.96 -21.98 9.28 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 114.292 -1.322 . . . . 0.0 112.165 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 pp -48.03 -32.56 6.78 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.725 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.545 HG23 ' H ' ' A' ' 19' ' ' PHE . 33.6 m -62.33 -57.81 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 123.696 0.623 . . . . 0.0 109.663 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.545 ' H ' HG23 ' A' ' 18' ' ' VAL . 32.1 m-85 -60.32 -42.94 96.66 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.419 0.628 . . . . 0.0 110.738 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -50.64 -13.33 0.13 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -126.81 -42.67 1.75 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 123.483 0.489 . . . . 0.0 110.806 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -77.16 -51.85 10.27 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.379 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.71 -40.41 96.71 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 117.963 -1.017 . . . . 0.0 112.543 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.6 m -57.25 -36.75 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.89 -50.42 52.97 Favored Glycine 0 N--CA 1.487 2.035 0 CA-C-N 112.946 -1.934 . . . . 0.0 108.763 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.548 ' HB3' HG11 ' A' ' 36' ' ' VAL . 33.9 m -52.13 -55.89 17.99 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 124.24 0.612 . . . . 0.0 112.051 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.521 ' HB2' HD11 ' A' ' 31' ' ' ILE . 23.6 p30 -83.34 -176.17 6.19 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.304 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.4 mttm 53.52 31.19 11.9 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 122.655 1.217 . . . . 0.0 111.253 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 174.81 29.56 0.03 OUTLIER Glycine 0 N--CA 1.485 1.947 0 CA-C-N 112.512 -2.131 . . . . 0.0 110.124 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -166.49 -21.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.915 -0.642 . . . . 0.0 110.192 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.521 HD11 ' HB2' ' A' ' 27' ' ' ASN . 35.9 mm -40.94 -32.01 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.0 tt -48.22 -30.56 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.99 -28.66 0.71 Allowed Glycine 0 N--CA 1.495 2.583 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 tt 59.33 72.7 0.51 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.378 1.085 . . . . 0.0 110.794 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.647 HG12 HG12 ' A' ' 39' ' ' VAL . 2.4 t -84.94 6.72 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-N 113.794 -1.548 . . . . 0.0 110.708 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 58.35 18.75 37.39 Favored Glycine 0 N--CA 1.498 2.819 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.344 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.13 36.82 76.58 Favored Glycine 0 N--CA 1.491 2.351 0 O-C-N 124.053 0.501 . . . . 0.0 112.01 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.647 HG12 HG12 ' A' ' 36' ' ' VAL . 5.5 p -89.23 30.18 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.953 0.882 . . . . 0.0 110.166 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.4 t . . . . . 0 N--CA 1.492 1.639 0 CA-C-N 113.645 -1.616 . . . . 0.0 109.363 179.892 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 120.978 0.418 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.38 60.07 3.96 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.005 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 52.94 26.3 4.59 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.878 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -41.33 136.8 1.59 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.96 76.34 10.05 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 39.81 37.53 0.36 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 112.738 -2.028 . . . . 0.0 113.746 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -165.71 118.08 1.12 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 113.489 -1.687 . . . . 0.0 109.793 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.3 p -173.92 118.84 0.26 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 124.242 0.964 . . . . 0.0 109.239 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.71 111.3 0.14 Allowed Glycine 0 N--CA 1.495 2.615 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.341 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -119.53 71.01 0.86 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -167.44 -28.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 113.499 -1.682 . . . . 0.0 109.974 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.423 HG13 ' CG ' ' A' ' 14' ' ' HIS . 3.0 p -61.74 161.71 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.622 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -99.69 40.22 1.25 Allowed 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.328 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.423 ' CG ' HG13 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -62.53 80.89 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 113.659 -1.61 . . . . 0.0 112.561 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.498 ' O ' HG22 ' A' ' 18' ' ' VAL . 8.3 pt20 -49.77 -23.63 1.93 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -49.32 -25.34 2.34 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.523 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -46.86 -30.55 2.55 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.225 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.555 HG23 ' H ' ' A' ' 19' ' ' PHE . 34.1 m -63.86 -58.01 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.555 ' H ' HG23 ' A' ' 18' ' ' VAL . 25.6 m-85 -58.29 -40.28 81.52 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.125 0.488 . . . . 0.0 110.867 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -45.2 -23.83 0.21 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 114.774 -1.103 . . . . 0.0 113.622 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.08 -40.52 2.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 123.734 0.646 . . . . 0.0 111.09 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -71.51 -51.13 25.28 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.929 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -62.14 -44.74 95.95 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.705 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.7 m -57.22 -35.05 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 118.901 -1.12 . . . . 0.0 107.981 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.89 -45.28 64.54 Favored Glycine 0 CA--C 1.544 1.901 0 CA-C-N 112.837 -1.983 . . . . 0.0 110.862 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.9 p -67.9 -46.03 72.75 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -71.76 161.26 31.23 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.97 40.26 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 113.882 -1.508 . . . . 0.0 108.948 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.49 54.4 0.3 Allowed Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.83 -68.01 0.19 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 23.3 mm -50.49 -25.57 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.248 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.8 tt -53.23 -25.2 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 115.117 -0.947 . . . . 0.0 113.471 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -139.42 -29.69 0.21 Allowed Glycine 0 N--CA 1.497 2.755 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 53.41 81.28 0.09 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.437 0.637 . . . . 0.0 111.252 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.6 t -61.48 -25.2 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.562 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.75 -46.85 0.64 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 176.27 34.22 0.05 OUTLIER Glycine 0 N--CA 1.485 1.965 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 t -97.28 26.45 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 122.119 0.961 . . . . 0.0 108.989 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 116.207 -1.854 . . . . 0.0 108.917 -179.939 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.37 48.51 21.09 Favored 'General case' 0 N--CA 1.502 2.135 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.938 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 45.29 80.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.726 -1.579 . . . . 0.0 110.732 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.449 ' HA ' ' HG2' ' A' ' 11' ' ' GLU . 43.5 p90 -92.97 142.91 26.77 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.353 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.414 ' HB2' ' CD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -86.36 62.04 7.19 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 124.015 0.822 . . . . 0.0 111.187 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.8 p80 27.09 45.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -164.36 143.41 7.37 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.242 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.0 t -60.18 129.33 41.17 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.015 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.43 6.2 83.56 Favored Glycine 0 N--CA 1.494 2.531 0 CA-C-N 115.028 -0.987 . . . . 0.0 113.118 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.414 ' CD1' ' HB2' ' A' ' 5' ' ' ARG . 0.2 OUTLIER -96.24 62.71 2.15 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.449 ' HG2' ' HA ' ' A' ' 4' ' ' PHE . 1.8 tm-20 -168.78 -2.55 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 111.122 -2.763 . . . . 0.0 109.47 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.27 155.02 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 CA-C-O 121.329 0.585 . . . . 0.0 111.492 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 41.58 36.21 0.55 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 113.074 -1.875 . . . . 0.0 111.653 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 -72.76 107.46 5.21 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.618 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -51.68 -19.42 1.58 Allowed 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.746 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -48.0 -23.72 0.88 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.214 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.3 mt -42.58 -33.52 0.71 Allowed 'General case' 0 N--CA 1.5 2.054 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.895 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.602 HG23 ' H ' ' A' ' 19' ' ' PHE . 34.4 m -63.5 -59.83 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.602 ' H ' HG23 ' A' ' 18' ' ' VAL . 25.8 m-85 -56.65 -37.44 70.79 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.507 0.67 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -42.59 -26.29 0.12 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 113.865 -1.516 . . . . 0.0 113.158 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.751 ' O ' HG22 ' A' ' 24' ' ' VAL . . . -124.3 -42.71 2.1 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 124.167 0.917 . . . . 0.0 110.077 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -67.22 -50.85 59.19 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.275 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -61.37 -33.76 74.18 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.697 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.751 HG22 ' O ' ' A' ' 21' ' ' ALA . 2.9 m -54.76 -42.01 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.55 -49.26 38.6 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.3 t -79.99 24.74 0.4 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 -70.1 168.25 15.98 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.213 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.2 pttm -179.79 33.72 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 113.747 -1.57 . . . . 0.0 109.426 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.14 39.88 0.03 OUTLIER Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.001 -1.639 . . . . 0.0 109.001 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.11 -58.39 0.38 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 54.6 mt -61.51 -56.09 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.8 tt -65.05 -30.14 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 114.146 -1.388 . . . . 0.0 108.675 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.88 18.14 27.97 Favored Glycine 0 N--CA 1.494 2.515 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.169 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.6 tp -156.91 82.57 0.94 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.2 t -69.4 -54.71 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.226 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.17 36.26 63.95 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.14 54.57 0.18 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 t -124.28 45.25 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.4 t . . . . . 0 N--CA 1.499 2.016 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.971 179.965 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 110.586 -0.153 . . . . 0.0 110.586 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.1 tp -41.29 -49.82 3.69 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.709 HG23 ' H ' ' A' ' 19' ' ' PHE . 31.0 m -51.81 -60.83 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 124.045 0.841 . . . . 0.0 110.923 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.709 ' H ' HG23 ' A' ' 18' ' ' VAL . 32.2 m-85 -60.19 -44.92 94.7 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.702 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -49.6 -8.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 124.974 1.421 . . . . 0.0 113.752 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 24' ' ' VAL . . . -118.23 -53.52 2.35 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -54.89 -38.29 67.38 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.07 -37.96 78.78 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.443 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.427 ' H ' HG13 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -61.92 -47.58 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 105.21 -2.145 . . . . 0.0 105.21 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.77 -46.68 93.65 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.486 1.367 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.916 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.402 ' HG3' ' HB2' ' A' ' 19' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 pp -49.28 -40.63 35.3 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.525 HG23 ' CD2' ' A' ' 19' ' ' PHE . 34.4 m -60.44 -54.44 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.709 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.525 ' CD2' HG23 ' A' ' 18' ' ' VAL . 77.8 m-85 -57.98 -44.93 87.4 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.477 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -46.95 -17.73 0.06 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 114.563 -1.198 . . . . 0.0 113.977 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -123.22 -44.18 2.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 123.799 0.687 . . . . 0.0 111.117 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -71.91 -51.92 19.79 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.766 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.29 -41.28 94.3 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.889 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.9 m -63.31 -36.39 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.05 -49.33 76.15 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.9 p . . . . . 0 N--CA 1.49 1.54 0 O-C-N 123.943 0.437 . . . . 0.0 112.045 179.891 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? . . . . . 0 N--CA 1.497 1.886 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.35 -34.56 10.88 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 123.781 0.676 . . . . 0.0 110.569 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.65 HG23 ' H ' ' A' ' 19' ' ' PHE . 35.5 m -58.71 -60.87 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.018 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.65 ' H ' HG23 ' A' ' 18' ' ' VAL . 24.0 m-85 -56.72 -40.75 76.23 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.521 0.677 . . . . 0.0 110.318 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -45.88 -23.29 0.27 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.297 -1.32 . . . . 0.0 114.097 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.07 -39.72 2.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 123.753 0.658 . . . . 0.0 110.571 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -73.37 -53.5 10.6 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.106 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.19 -36.07 82.86 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.1 m -61.75 -38.94 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.57 -54.13 36.31 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.579 -2.208 . . . . 0.0 107.579 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.858 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.635 0.255 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 pp -46.72 -33.58 4.44 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.895 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.543 HG23 ' N ' ' A' ' 19' ' ' PHE . 34.0 m -62.19 -57.03 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 O-C-N 123.877 0.735 . . . . 0.0 109.53 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.543 ' N ' HG23 ' A' ' 18' ' ' VAL . 31.2 m-85 -59.46 -41.92 90.79 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.342 0.591 . . . . 0.0 110.319 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -48.57 -16.06 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 114.317 -1.31 . . . . 0.0 114.138 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -125.85 -43.78 1.83 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 123.738 0.649 . . . . 0.0 110.655 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -73.17 -53.68 10.37 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.773 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.24 -40.19 93.71 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 117.924 -1.036 . . . . 0.0 112.191 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.2 m -60.01 -37.33 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.92 -51.41 59.34 Favored Glycine 0 N--CA 1.489 2.171 0 CA-C-N 113.097 -1.865 . . . . 0.0 109.064 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.497 1.879 0 O-C-N 124.629 0.841 . . . . 0.0 111.212 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 121.721 0.772 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.478 ' O ' HD23 ' A' ' 17' ' ' LEU . 4.7 tt -52.5 -25.96 11.72 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.107 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.541 HG23 ' N ' ' A' ' 19' ' ' PHE . 33.3 m -65.77 -53.98 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.541 ' N ' HG23 ' A' ' 18' ' ' VAL . 27.8 m-85 -59.11 -41.6 88.55 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.715 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -46.45 -19.17 0.07 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 114.19 -1.368 . . . . 0.0 113.589 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -127.46 -40.53 1.78 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 123.566 0.541 . . . . 0.0 111.067 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -75.21 -49.58 18.92 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.532 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.16 -39.75 86.55 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.939 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.3 m -61.36 -37.43 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.79 -45.74 95.1 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.8 m . . . . . 0 N--CA 1.489 1.522 0 CA-C-N 115.042 -0.579 . . . . 0.0 111.156 179.776 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.1 pp -51.65 -41.02 61.03 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.639 HG23 ' H ' ' A' ' 19' ' ' PHE . 26.7 m -58.67 -60.9 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.355 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.639 ' H ' HG23 ' A' ' 18' ' ' VAL . 19.6 m-30 -61.01 -37.3 82.06 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -47.39 -19.9 0.19 Allowed 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -120.21 -43.76 2.52 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 123.902 0.751 . . . . 0.0 109.259 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -69.19 -57.52 5.26 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.575 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.92 -36.63 81.93 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.0 m -63.81 -38.72 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.92 -51.04 61.05 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 107.451 -2.26 . . . . 0.0 107.451 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.487 1.38 0 O-C-N 124.348 0.675 . . . . 0.0 109.4 179.852 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 tt -44.53 -32.16 1.33 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 123.892 0.745 . . . . 0.0 112.5 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.621 HG23 ' H ' ' A' ' 19' ' ' PHE . 31.8 m -66.53 -59.6 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.75 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.621 ' H ' HG23 ' A' ' 18' ' ' VAL . 32.5 m-85 -57.23 -38.14 73.34 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.164 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -39.11 -31.37 0.07 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.176 -1.375 . . . . 0.0 112.828 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.33 -49.23 2.05 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 124.546 1.154 . . . . 0.0 109.925 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -58.95 -47.39 85.25 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.46 -0.496 . . . . 0.0 112.209 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.47 -38.68 90.78 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 118.964 -1.095 . . . . 0.0 111.846 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -55.49 -47.62 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.48 -49.72 67.39 Favored Glycine 0 N--CA 1.489 2.184 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.931 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.499 1.984 0 CA-C-O 121.308 0.575 . . . . 0.0 110.549 179.895 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 pp -48.03 -32.56 6.78 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.725 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.545 HG23 ' N ' ' A' ' 19' ' ' PHE . 33.6 m -62.33 -57.81 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 123.696 0.623 . . . . 0.0 109.663 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.545 ' N ' HG23 ' A' ' 18' ' ' VAL . 32.1 m-85 -60.32 -42.94 96.66 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.419 0.628 . . . . 0.0 110.738 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -50.64 -13.33 0.13 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -126.81 -42.67 1.75 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 123.483 0.489 . . . . 0.0 110.806 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -77.16 -51.85 10.27 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.379 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.71 -40.41 96.71 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 117.963 -1.017 . . . . 0.0 112.543 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.6 m -57.25 -36.75 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.89 -50.42 52.97 Favored Glycine 0 N--CA 1.487 2.035 0 CA-C-N 112.946 -1.934 . . . . 0.0 108.763 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.9 m . . . . . 0 N--CA 1.497 1.902 0 O-C-N 124.24 0.612 . . . . 0.0 112.051 179.973 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -46.86 -30.55 2.55 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.225 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.555 HG23 ' H ' ' A' ' 19' ' ' PHE . 34.1 m -63.86 -58.01 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.555 ' H ' HG23 ' A' ' 18' ' ' VAL . 25.6 m-85 -58.29 -40.28 81.52 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.125 0.488 . . . . 0.0 110.867 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -45.2 -23.83 0.21 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 114.774 -1.103 . . . . 0.0 113.622 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.08 -40.52 2.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 123.734 0.646 . . . . 0.0 111.09 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -71.51 -51.13 25.28 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.929 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -62.14 -44.74 95.95 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.705 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.7 m -57.22 -35.05 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 118.901 -1.12 . . . . 0.0 107.981 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.89 -45.28 64.54 Favored Glycine 0 CA--C 1.544 1.901 0 CA-C-N 112.837 -1.983 . . . . 0.0 110.862 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.9 p . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -179.787 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 120.549 0.214 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.3 mt -42.58 -33.52 0.71 Allowed 'General case' 0 N--CA 1.5 2.054 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.895 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.602 HG23 ' H ' ' A' ' 19' ' ' PHE . 34.4 m -63.5 -59.83 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.602 ' H ' HG23 ' A' ' 18' ' ' VAL . 25.8 m-85 -56.65 -37.44 70.79 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.507 0.67 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -42.59 -26.29 0.12 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 113.865 -1.516 . . . . 0.0 113.158 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.751 ' O ' HG22 ' A' ' 24' ' ' VAL . . . -124.3 -42.71 2.1 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 124.167 0.917 . . . . 0.0 110.077 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -67.22 -50.85 59.19 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.275 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -61.37 -33.76 74.18 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.697 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.751 HG22 ' O ' ' A' ' 21' ' ' ALA . 2.9 m -54.76 -42.01 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.55 -49.26 38.6 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 179.959 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 30.1 t70 . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.32 53.37 1.3 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 124.555 1.16 . . . . 0.0 111.159 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -89.12 38.87 0.91 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.495 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -64.7 148.71 50.52 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.022 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -137.17 43.64 2.34 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.645 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.6 33.09 0.36 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.806 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.37 124.73 21.7 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.52 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.0 m -65.85 -169.9 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.356 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.15 -57.82 0.78 Allowed Glycine 0 N--CA 1.497 2.748 0 N-CA-C 105.481 -3.047 . . . . 0.0 105.481 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -124.53 36.58 4.58 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -168.49 162.08 12.03 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 112.694 -2.048 . . . . 0.0 108.928 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -60.97 151.83 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.622 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.493 ' CD2' HE22 ' A' ' 15' ' ' GLN . 17.4 t-80 -99.96 28.73 4.62 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.23 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -100.89 46.23 0.95 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.953 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.592 ' H ' HE21 ' A' ' 15' ' ' GLN . 0.1 OUTLIER -62.43 -4.52 1.92 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.832 179.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.68 -41.84 23.03 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.586 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.1 tp -41.29 -49.82 3.69 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.709 HG23 ' H ' ' A' ' 19' ' ' PHE . 31.0 m -51.81 -60.83 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 124.045 0.841 . . . . 0.0 110.923 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.709 ' H ' HG23 ' A' ' 18' ' ' VAL . 32.2 m-85 -60.19 -44.92 94.7 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.702 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -49.6 -8.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 124.974 1.421 . . . . 0.0 113.752 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 24' ' ' VAL . . . -118.23 -53.52 2.35 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -54.89 -38.29 67.38 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.07 -37.96 78.78 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.443 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.427 ' H ' HG13 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -61.92 -47.58 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 105.21 -2.145 . . . . 0.0 105.21 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.77 -46.68 93.65 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.1 t -92.29 40.22 1.04 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -48.65 150.05 1.52 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 114.953 -1.021 . . . . 0.0 113.102 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.74 43.09 0.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 113.76 -1.564 . . . . 0.0 107.046 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.46 20.8 18.19 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.16 20.69 3.5 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 124.542 0.79 . . . . 0.0 112.41 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 55.9 mt -55.27 -26.96 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.055 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.5 tt -50.25 -30.48 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 124.442 1.089 . . . . 0.0 111.854 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.33 -39.68 1.61 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 107.248 -2.341 . . . . 0.0 107.248 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 57.76 32.9 22.55 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 122.176 0.989 . . . . 0.0 111.083 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.2 p -60.09 -42.44 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.373 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.82 36.1 0.45 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.07 49.72 0.19 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.3 t -97.14 34.24 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 115.049 -2.405 . . . . 0.0 111.178 -179.999 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 t70 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 122.016 0.913 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -170.44 62.83 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -121.22 10.57 10.67 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 112.886 -1.961 . . . . 0.0 110.837 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -63.91 125.97 26.12 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.345 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 47.51 42.61 14.89 Favored 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.619 0.723 . . . . 0.0 109.4 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 30.3 p80 38.97 37.87 0.25 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 113.773 -1.558 . . . . 0.0 114.649 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -49.02 98.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.205 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m -168.3 39.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 112.742 -2.026 . . . . 0.0 105.722 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 10' ' ' TYR . . . -157.43 -29.12 0.02 OUTLIER Glycine 0 N--CA 1.494 2.561 0 CA-C-N 113.178 -1.828 . . . . 0.0 108.549 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.407 ' H ' ' H ' ' A' ' 9' ' ' GLY . 18.6 t80 -102.24 51.89 0.81 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.21 148.29 8.2 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 113.228 -1.805 . . . . 0.0 109.714 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 p -61.24 152.39 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.612 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 45.1 39.51 3.96 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.397 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -56.97 85.03 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 113.273 -1.785 . . . . 0.0 111.429 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -144.74 72.24 1.33 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.297 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.402 ' HG3' ' HB2' ' A' ' 19' ' ' PHE . 0.1 OUTLIER 55.53 14.9 1.3 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.763 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 pp -49.28 -40.63 35.3 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.525 HG23 ' CD2' ' A' ' 19' ' ' PHE . 34.4 m -60.44 -54.44 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.709 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.525 ' CD2' HG23 ' A' ' 18' ' ' VAL . 77.8 m-85 -57.98 -44.93 87.4 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.477 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -46.95 -17.73 0.06 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 114.563 -1.198 . . . . 0.0 113.977 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -123.22 -44.18 2.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 123.799 0.687 . . . . 0.0 111.117 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -71.91 -51.92 19.79 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.766 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.29 -41.28 94.3 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.889 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.9 m -63.31 -36.39 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.05 -49.33 76.15 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.9 p -82.05 32.49 0.38 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 123.943 0.437 . . . . 0.0 112.045 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -58.79 161.81 4.53 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.983 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -165.26 40.57 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.576 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 56.35 22.22 36.67 Favored Glycine 0 N--CA 1.494 2.565 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.714 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.9 -45.3 0.73 Allowed 'General case' 0 N--CA 1.484 1.251 0 O-C-N 124.592 0.819 . . . . 0.0 108.997 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.3 mm -53.31 -31.65 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 123.8 0.687 . . . . 0.0 111.148 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.1 mm -51.72 -55.6 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 124.652 1.22 . . . . 0.0 110.432 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.53 -39.36 25.92 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 60.17 44.31 12.97 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 122.686 1.231 . . . . 0.0 109.205 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.8 p -56.76 -35.96 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 124.092 0.87 . . . . 0.0 111.582 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.53 51.92 2.42 Favored Glycine 0 N--CA 1.494 2.512 0 CA-C-N 113.878 -1.51 . . . . 0.0 109.392 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.48 43.65 0.26 Allowed Glycine 0 N--CA 1.487 2.036 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.9 p -89.96 27.68 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.288 1.042 . . . . 0.0 110.081 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.5 p . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 116.182 -1.866 . . . . 0.0 111.685 -179.968 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 29.9 t70 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.7 39.32 17.37 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-N 114.992 -1.004 . . . . 0.0 112.204 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.69 66.58 4.44 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.004 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -73.23 146.86 45.17 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.256 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -83.9 -118.8 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.38 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.8 t60 18.35 64.78 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 125.521 1.763 . . . . 0.0 113.163 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.3 94.42 0.11 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 112.979 -1.919 . . . . 0.0 112.057 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.8 m -115.42 123.27 48.21 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 63.48 41.47 99.26 Favored Glycine 0 N--CA 1.501 2.974 0 N-CA-C 107.814 -2.114 . . . . 0.0 107.814 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -99.78 57.36 1.0 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -161.11 -68.09 0.06 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 113.958 -1.474 . . . . 0.0 111.869 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 t -135.34 158.11 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 123.827 0.705 . . . . 0.0 109.963 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -132.78 47.47 2.51 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.011 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.425 ' CD2' HE21 ' A' ' 15' ' ' GLN . 8.7 p80 -87.11 37.6 0.77 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.369 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.495 ' O ' HG22 ' A' ' 18' ' ' VAL . 15.1 mt-30 -135.88 -86.4 0.35 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.89 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -52.71 -17.64 1.42 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.35 -34.56 10.88 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 123.781 0.676 . . . . 0.0 110.569 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.65 HG23 ' H ' ' A' ' 19' ' ' PHE . 35.5 m -58.71 -60.87 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.018 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.65 ' H ' HG23 ' A' ' 18' ' ' VAL . 24.0 m-85 -56.72 -40.75 76.23 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.521 0.677 . . . . 0.0 110.318 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -45.88 -23.29 0.27 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.297 -1.32 . . . . 0.0 114.097 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.07 -39.72 2.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 123.753 0.658 . . . . 0.0 110.571 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -73.37 -53.5 10.6 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.106 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.19 -36.07 82.86 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.1 m -61.75 -38.94 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.57 -54.13 36.31 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 107.579 -2.208 . . . . 0.0 107.579 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.6 m -94.21 52.64 1.62 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -51.02 148.66 4.13 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 114.482 -1.236 . . . . 0.0 112.415 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -165.95 42.05 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.291 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.76 45.8 0.07 OUTLIER Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.51 -46.53 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 114.977 -0.612 . . . . 0.0 109.53 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.4 mp -43.43 -31.51 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.0 tt -51.74 -27.3 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -158.61 -0.86 0.08 OUTLIER Glycine 0 N--CA 1.499 2.845 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.912 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 34.36 35.04 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.1 p -62.31 -41.19 90.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.026 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -162.5 -39.29 0.02 OUTLIER Glycine 0 N--CA 1.493 2.439 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.902 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.38 41.01 92.94 Favored Glycine 0 N--CA 1.493 2.498 0 O-C-N 124.139 0.552 . . . . 0.0 111.771 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 t -97.99 33.82 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-O 122.126 0.965 . . . . 0.0 108.809 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.493 1.696 0 CA-C-N 113.788 -1.551 . . . . 0.0 111.912 179.864 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.663 0.744 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.72 66.79 0.26 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.129 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 35.33 78.93 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 113.889 -1.505 . . . . 0.0 114.23 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -57.85 145.96 33.48 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.908 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 50.0 61.49 3.15 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 124.281 0.988 . . . . 0.0 110.387 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -83.0 57.9 4.13 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.087 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -58.43 149.96 23.67 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.628 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.2 t 67.14 124.02 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 124.782 1.302 . . . . 0.0 111.21 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.26 -58.57 7.13 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.412 ' H ' ' H ' ' A' ' 11' ' ' GLU . 27.8 t80 -147.86 -11.97 0.38 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.614 0.721 . . . . 0.0 109.828 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.419 ' CD ' ' H ' ' A' ' 11' ' ' GLU . 4.6 mp0 -78.33 20.02 0.43 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.012 -1.449 . . . . 0.0 111.864 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.716 HG22 ' H ' ' A' ' 13' ' ' HIS . 7.1 p -68.65 -178.25 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-O 121.267 0.556 . . . . 0.0 111.105 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.716 ' H ' HG22 ' A' ' 12' ' ' VAL . 2.6 t-160 -106.97 47.29 0.89 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.878 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -47.53 91.26 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 112.878 -1.965 . . . . 0.0 110.596 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -179.57 -47.64 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -63.6 -12.17 31.01 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 113.708 -1.587 . . . . 0.0 110.717 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 pp -46.72 -33.58 4.44 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.895 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.543 HG23 ' N ' ' A' ' 19' ' ' PHE . 34.0 m -62.19 -57.03 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 O-C-N 123.877 0.735 . . . . 0.0 109.53 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.543 ' N ' HG23 ' A' ' 18' ' ' VAL . 31.2 m-85 -59.46 -41.92 90.79 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.342 0.591 . . . . 0.0 110.319 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -48.57 -16.06 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 114.317 -1.31 . . . . 0.0 114.138 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -125.85 -43.78 1.83 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 123.738 0.649 . . . . 0.0 110.655 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -73.17 -53.68 10.37 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.773 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.24 -40.19 93.71 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 117.924 -1.036 . . . . 0.0 112.191 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.2 m -60.01 -37.33 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.92 -51.41 59.34 Favored Glycine 0 N--CA 1.489 2.171 0 CA-C-N 113.097 -1.865 . . . . 0.0 109.064 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.0 m -59.91 -50.44 73.77 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 124.629 0.841 . . . . 0.0 111.212 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -74.45 -170.92 1.09 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 114.242 -1.344 . . . . 0.0 110.848 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HB3' HD12 ' A' ' 31' ' ' ILE . 5.9 tttt 54.47 67.0 1.08 Allowed 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 122.436 1.112 . . . . 0.0 108.521 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.89 24.63 3.2 Favored Glycine 0 N--CA 1.497 2.71 0 CA-C-N 112.676 -2.056 . . . . 0.0 112.807 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.89 36.56 21.99 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.469 HD12 ' HB3' ' A' ' 28' ' ' LYS . 29.6 mt -40.65 -30.39 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -46.01 -31.4 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 124.202 0.939 . . . . 0.0 112.235 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -141.89 46.08 0.9 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.8 tp -165.5 101.56 0.71 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.2 t -64.0 -24.76 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.859 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.06 29.89 9.32 Favored Glycine 0 N--CA 1.497 2.73 0 O-C-N 123.955 0.784 . . . . 0.0 111.309 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.06 41.0 97.82 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 124.06 0.506 . . . . 0.0 112.229 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.3 t -110.75 41.99 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.498 1.971 0 CA-C-O 114.974 -2.441 . . . . 0.0 111.163 179.941 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.0 105.85 0.2 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 123.855 0.722 . . . . 0.0 109.614 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.51 65.41 7.86 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -73.86 179.12 4.44 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 114.017 -1.447 . . . . 0.0 113.733 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.68 53.18 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -80.93 26.4 0.42 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.205 -1.362 . . . . 0.0 113.392 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -66.3 149.05 50.94 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 113.357 -1.747 . . . . 0.0 111.988 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 m 51.58 43.51 29.71 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 122.408 1.099 . . . . 0.0 109.615 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -147.73 -64.69 0.01 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 107.342 -2.303 . . . . 0.0 107.342 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -137.08 12.13 3.07 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -159.32 171.19 20.26 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.533 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.58 HG22 ' H ' ' A' ' 13' ' ' HIS . 5.1 p -59.74 173.88 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 124.355 1.034 . . . . 0.0 112.102 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.58 ' H ' HG22 ' A' ' 12' ' ' VAL . 8.4 t-160 -141.36 55.87 1.53 Allowed 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.915 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -58.78 133.78 56.27 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 113.578 -1.646 . . . . 0.0 110.407 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.593 ' O ' HG22 ' A' ' 18' ' ' VAL . 6.7 tt0 -91.63 -118.82 0.07 Allowed 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.462 ' NZ ' HE21 ' A' ' 15' ' ' GLN . 38.1 mmtm -54.03 -25.73 22.87 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.721 0.772 . . . . 0.0 111.014 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.478 ' O ' HD23 ' A' ' 17' ' ' LEU . 4.7 tt -52.5 -25.96 11.72 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.107 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 15' ' ' GLN . 33.3 m -65.77 -53.98 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.541 ' N ' HG23 ' A' ' 18' ' ' VAL . 27.8 m-85 -59.11 -41.6 88.55 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.715 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -46.45 -19.17 0.07 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 114.19 -1.368 . . . . 0.0 113.589 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -127.46 -40.53 1.78 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 123.566 0.541 . . . . 0.0 111.067 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -75.21 -49.58 18.92 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.532 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.16 -39.75 86.55 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.939 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.3 m -61.36 -37.43 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.79 -45.74 95.1 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 107.895 -2.082 . . . . 0.0 107.895 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.8 m -82.69 31.56 0.42 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.042 -0.579 . . . . 0.0 111.156 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -58.9 167.26 1.65 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? 57.93 64.95 1.4 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 122.721 1.248 . . . . 0.0 108.904 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 43.88 33.48 2.59 Favored Glycine 0 N--CA 1.498 2.788 0 CA-C-N 112.162 -2.29 . . . . 0.0 113.658 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.2 21.18 2.11 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.3 mm -51.12 -31.8 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 120.636 0.255 . . . . 0.0 111.17 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.9 tt -47.44 -26.89 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 124.58 1.175 . . . . 0.0 113.521 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.74 54.59 0.43 Allowed Glycine 0 N--CA 1.494 2.537 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.39 41.01 0.59 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 114.876 -0.662 . . . . 0.0 112.737 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.483 HG13 ' N ' ' A' ' 37' ' ' GLY . 9.2 p -67.71 -51.26 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 123.901 0.751 . . . . 0.0 111.973 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.483 ' N ' HG13 ' A' ' 36' ' ' VAL . . . 119.77 58.01 0.25 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.51 65.11 2.69 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.7 p 43.68 30.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 125.306 1.239 . . . . 0.0 112.638 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.422 ' C ' HG22 ' A' ' 36' ' ' VAL . 57.1 t . . . . . 0 N--CA 1.489 1.521 0 CA-C-N 112.808 -1.996 . . . . 0.0 107.477 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.51 97.57 0.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.152 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -136.44 87.12 2.27 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.166 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -65.01 122.18 16.41 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.373 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -145.46 76.46 1.48 Allowed 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.922 0.868 . . . . 0.0 109.332 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -82.89 40.16 0.67 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 113.969 -1.469 . . . . 0.0 111.386 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 8' ' ' SER . 28.8 t0 57.45 -166.79 0.14 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.946 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.41 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 7.4 p 56.21 -166.28 0.12 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 66.94 -99.57 0.5 Allowed Glycine 0 N--CA 1.498 2.773 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -107.14 44.4 1.07 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.2 167.73 25.52 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 113.221 -1.809 . . . . 0.0 110.204 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 13' ' ' HIS . 23.0 t -57.7 164.43 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.387 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.413 ' N ' HG12 ' A' ' 12' ' ' VAL . 17.8 t-80 -103.51 35.63 2.54 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.549 0.69 . . . . 0.0 109.98 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.3 42.05 0.92 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.831 1.3 . . . . 0.0 109.652 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -55.7 -17.55 6.15 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.25 -1.796 . . . . 0.0 112.031 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -71.97 -71.46 0.28 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.761 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.1 pp -51.65 -41.02 61.03 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.639 HG23 ' H ' ' A' ' 19' ' ' PHE . 26.7 m -58.67 -60.9 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.355 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.639 ' H ' HG23 ' A' ' 18' ' ' VAL . 19.6 m-30 -61.01 -37.3 82.06 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -47.39 -19.9 0.19 Allowed 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -120.21 -43.76 2.52 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 123.902 0.751 . . . . 0.0 109.259 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -69.19 -57.52 5.26 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.575 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.92 -36.63 81.93 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.0 m -63.81 -38.72 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.92 -51.04 61.05 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 107.451 -2.26 . . . . 0.0 107.451 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.9 t -90.23 43.28 1.14 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 124.348 0.675 . . . . 0.0 109.4 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -56.58 157.13 5.49 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.65 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.4 mttt 56.28 20.72 4.79 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.323 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.4 23.32 28.8 Favored Glycine 0 N--CA 1.489 2.228 0 CA-C-N 113.273 -1.785 . . . . 0.0 109.454 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -171.42 -58.81 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.448 ' H ' HD12 ' A' ' 31' ' ' ILE . 2.1 mp -53.04 -31.06 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.53 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.0 tt -52.32 -24.29 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-N 114.532 -1.213 . . . . 0.0 113.452 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -121.51 -46.03 0.33 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.1 tp 33.54 48.49 0.19 Allowed 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 p -59.57 -30.89 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.463 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.48 23.66 10.06 Favored Glycine 0 N--CA 1.497 2.715 0 CA-C-N 113.991 -1.459 . . . . 0.0 111.326 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 53.9 37.23 57.39 Favored Glycine 0 N--CA 1.495 2.611 0 O-C-N 124.141 0.554 . . . . 0.0 111.876 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.0 p -93.23 29.18 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 122.178 0.99 . . . . 0.0 110.356 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 116.4 -1.762 . . . . 0.0 110.368 -179.959 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.5 t70 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.42 59.72 4.92 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.209 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 50.95 35.49 12.72 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.833 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -130.03 -161.84 1.15 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.141 -1.39 . . . . 0.0 110.058 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.9 ttt85 54.22 88.73 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 124.033 0.833 . . . . 0.0 112.77 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -86.29 38.58 0.78 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.799 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.07 128.54 34.21 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.299 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 p -170.94 142.99 1.95 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.355 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.7 163.95 34.41 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -145.37 -40.3 0.24 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.562 0.696 . . . . 0.0 109.624 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -58.01 126.2 26.42 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 113.528 -1.669 . . . . 0.0 110.145 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.751 HG22 ' H ' ' A' ' 13' ' ' HIS . 6.4 p 43.46 -151.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 123.707 0.629 . . . . 0.0 111.799 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.751 ' H ' HG22 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -117.33 42.13 2.63 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.374 0.607 . . . . 0.0 110.181 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.51 63.46 1.09 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.355 -1.293 . . . . 0.0 112.276 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.537 ' O ' HG22 ' A' ' 18' ' ' VAL . 30.5 tt0 -169.55 -77.51 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -52.58 -26.04 12.26 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 tt -44.53 -32.16 1.33 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 123.892 0.745 . . . . 0.0 112.5 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.621 HG23 ' H ' ' A' ' 19' ' ' PHE . 31.8 m -66.53 -59.6 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.75 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.621 ' H ' HG23 ' A' ' 18' ' ' VAL . 32.5 m-85 -57.23 -38.14 73.34 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.164 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -39.11 -31.37 0.07 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.176 -1.375 . . . . 0.0 112.828 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.33 -49.23 2.05 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 124.546 1.154 . . . . 0.0 109.925 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -58.95 -47.39 85.25 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 120.46 -0.496 . . . . 0.0 112.209 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.47 -38.68 90.78 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 118.964 -1.095 . . . . 0.0 111.846 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -55.49 -47.62 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.48 -49.72 67.39 Favored Glycine 0 N--CA 1.489 2.184 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.931 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.5 m -53.47 -51.25 63.32 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.308 0.575 . . . . 0.0 110.549 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -62.28 166.37 5.03 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.874 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -126.47 43.98 2.98 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.237 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -173.91 -41.31 0.04 OUTLIER Glycine 0 N--CA 1.487 2.097 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.974 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -48.24 -33.62 8.95 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.78 ' H ' HD12 ' A' ' 31' ' ' ILE . 3.1 mp -58.81 -67.09 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.598 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.1 tt -61.01 -37.63 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 123.489 0.493 . . . . 0.0 111.375 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.73 13.05 7.19 Favored Glycine 0 N--CA 1.495 2.611 0 O-C-N 123.75 0.657 . . . . 0.0 112.826 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -156.17 96.98 1.75 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.429 HG11 HG12 ' A' ' 40' ' ' VAL . 10.7 p -55.08 -42.27 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.836 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.42 ' N ' HG13 ' A' ' 36' ' ' VAL . . . 172.37 -20.22 0.06 OUTLIER Glycine 0 N--CA 1.493 2.454 0 CA-C-N 113.186 -1.825 . . . . 0.0 109.467 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -166.79 33.53 0.22 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.5 p 38.09 45.67 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 CA-C-O 122.79 1.281 . . . . 0.0 112.356 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.429 HG12 HG11 ' A' ' 36' ' ' VAL . 3.5 p . . . . . 0 N--CA 1.497 1.912 0 CA-C-N 112.702 -2.045 . . . . 0.0 113.377 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.5 t70 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 47.66 79.38 0.06 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 124.694 1.246 . . . . 0.0 112.216 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 51.98 29.33 6.07 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.862 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.21 -170.57 3.17 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.13 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.6 ttp85 -152.57 37.1 0.52 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.17 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -86.75 52.19 2.44 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.879 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -71.5 88.68 0.93 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.634 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 t 60.75 -176.95 0.11 Allowed 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.308 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.59 -30.98 63.42 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -155.51 123.29 5.68 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.99 85.41 0.15 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 124.154 0.909 . . . . 0.0 109.811 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 p -70.37 151.66 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.472 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 43.09 37.58 1.23 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.383 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -59.13 113.23 2.02 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 113.093 -1.867 . . . . 0.0 112.1 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.521 ' O ' HG22 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -166.59 -57.69 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.96 -21.98 9.28 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 114.292 -1.322 . . . . 0.0 112.165 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 pp -48.03 -32.56 6.78 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.725 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.545 HG23 ' N ' ' A' ' 19' ' ' PHE . 33.6 m -62.33 -57.81 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 123.696 0.623 . . . . 0.0 109.663 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.545 ' N ' HG23 ' A' ' 18' ' ' VAL . 32.1 m-85 -60.32 -42.94 96.66 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.419 0.628 . . . . 0.0 110.738 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -50.64 -13.33 0.13 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -126.81 -42.67 1.75 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 123.483 0.489 . . . . 0.0 110.806 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -77.16 -51.85 10.27 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.379 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.71 -40.41 96.71 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 117.963 -1.017 . . . . 0.0 112.543 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.6 m -57.25 -36.75 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.89 -50.42 52.97 Favored Glycine 0 N--CA 1.487 2.035 0 CA-C-N 112.946 -1.934 . . . . 0.0 108.763 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.548 ' HB3' HG11 ' A' ' 36' ' ' VAL . 33.9 m -52.13 -55.89 17.99 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 124.24 0.612 . . . . 0.0 112.051 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.521 ' HB2' HD11 ' A' ' 31' ' ' ILE . 23.6 p30 -83.34 -176.17 6.19 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.304 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.4 mttm 53.52 31.19 11.9 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-O 122.655 1.217 . . . . 0.0 111.253 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 174.81 29.56 0.03 OUTLIER Glycine 0 N--CA 1.485 1.947 0 CA-C-N 112.512 -2.131 . . . . 0.0 110.124 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -166.49 -21.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.915 -0.642 . . . . 0.0 110.192 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.521 HD11 ' HB2' ' A' ' 27' ' ' ASN . 35.9 mm -40.94 -32.01 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.0 tt -48.22 -30.56 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.99 -28.66 0.71 Allowed Glycine 0 N--CA 1.495 2.583 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 tt 59.33 72.7 0.51 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.378 1.085 . . . . 0.0 110.794 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.647 HG12 HG12 ' A' ' 39' ' ' VAL . 2.4 t -84.94 6.72 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-N 113.794 -1.548 . . . . 0.0 110.708 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 58.35 18.75 37.39 Favored Glycine 0 N--CA 1.498 2.819 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.344 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 57.13 36.82 76.58 Favored Glycine 0 N--CA 1.491 2.351 0 O-C-N 124.053 0.501 . . . . 0.0 112.01 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.647 HG12 HG12 ' A' ' 36' ' ' VAL . 5.5 p -89.23 30.18 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.953 0.882 . . . . 0.0 110.166 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.4 t . . . . . 0 N--CA 1.492 1.639 0 CA-C-N 113.645 -1.616 . . . . 0.0 109.363 179.892 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 120.978 0.418 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.38 60.07 3.96 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.005 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 52.94 26.3 4.59 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.878 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -41.33 136.8 1.59 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.96 76.34 10.05 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 39.81 37.53 0.36 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 112.738 -2.028 . . . . 0.0 113.746 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -165.71 118.08 1.12 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 113.489 -1.687 . . . . 0.0 109.793 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.3 p -173.92 118.84 0.26 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 124.242 0.964 . . . . 0.0 109.239 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.71 111.3 0.14 Allowed Glycine 0 N--CA 1.495 2.615 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.341 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -119.53 71.01 0.86 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -167.44 -28.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 113.499 -1.682 . . . . 0.0 109.974 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.423 HG13 ' CG ' ' A' ' 14' ' ' HIS . 3.0 p -61.74 161.71 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.622 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -99.69 40.22 1.25 Allowed 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.328 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.423 ' CG ' HG13 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -62.53 80.89 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 113.659 -1.61 . . . . 0.0 112.561 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.498 ' O ' HG22 ' A' ' 18' ' ' VAL . 8.3 pt20 -49.77 -23.63 1.93 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -49.32 -25.34 2.34 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.523 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -46.86 -30.55 2.55 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.225 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.555 HG23 ' H ' ' A' ' 19' ' ' PHE . 34.1 m -63.86 -58.01 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.555 ' H ' HG23 ' A' ' 18' ' ' VAL . 25.6 m-85 -58.29 -40.28 81.52 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.125 0.488 . . . . 0.0 110.867 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -45.2 -23.83 0.21 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 114.774 -1.103 . . . . 0.0 113.622 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.08 -40.52 2.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 123.734 0.646 . . . . 0.0 111.09 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -71.51 -51.13 25.28 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.929 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -62.14 -44.74 95.95 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.705 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.7 m -57.22 -35.05 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 118.901 -1.12 . . . . 0.0 107.981 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.89 -45.28 64.54 Favored Glycine 0 CA--C 1.544 1.901 0 CA-C-N 112.837 -1.983 . . . . 0.0 110.862 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.9 p -67.9 -46.03 72.75 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -71.76 161.26 31.23 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.97 40.26 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 113.882 -1.508 . . . . 0.0 108.948 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.49 54.4 0.3 Allowed Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.83 -68.01 0.19 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 23.3 mm -50.49 -25.57 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.248 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.8 tt -53.23 -25.2 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 115.117 -0.947 . . . . 0.0 113.471 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -139.42 -29.69 0.21 Allowed Glycine 0 N--CA 1.497 2.755 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 53.41 81.28 0.09 Allowed 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.437 0.637 . . . . 0.0 111.252 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.6 t -61.48 -25.2 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.562 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.75 -46.85 0.64 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 176.27 34.22 0.05 OUTLIER Glycine 0 N--CA 1.485 1.965 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 t -97.28 26.45 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 122.119 0.961 . . . . 0.0 108.989 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 116.207 -1.854 . . . . 0.0 108.917 -179.939 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.37 48.51 21.09 Favored 'General case' 0 N--CA 1.502 2.135 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.938 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 45.29 80.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 113.726 -1.579 . . . . 0.0 110.732 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.449 ' HA ' ' HG2' ' A' ' 11' ' ' GLU . 43.5 p90 -92.97 142.91 26.77 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.353 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.414 ' HB2' ' CD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -86.36 62.04 7.19 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 124.015 0.822 . . . . 0.0 111.187 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.8 p80 27.09 45.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -164.36 143.41 7.37 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.242 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.0 t -60.18 129.33 41.17 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.015 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.43 6.2 83.56 Favored Glycine 0 N--CA 1.494 2.531 0 CA-C-N 115.028 -0.987 . . . . 0.0 113.118 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.414 ' CD1' ' HB2' ' A' ' 5' ' ' ARG . 0.2 OUTLIER -96.24 62.71 2.15 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.449 ' HG2' ' HA ' ' A' ' 4' ' ' PHE . 1.8 tm-20 -168.78 -2.55 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 111.122 -2.763 . . . . 0.0 109.47 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.27 155.02 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 CA-C-O 121.329 0.585 . . . . 0.0 111.492 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 41.58 36.21 0.55 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 113.074 -1.875 . . . . 0.0 111.653 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 -72.76 107.46 5.21 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.618 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -51.68 -19.42 1.58 Allowed 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.746 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -48.0 -23.72 0.88 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.214 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.3 mt -42.58 -33.52 0.71 Allowed 'General case' 0 N--CA 1.5 2.054 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.895 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.602 HG23 ' H ' ' A' ' 19' ' ' PHE . 34.4 m -63.5 -59.83 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.602 ' H ' HG23 ' A' ' 18' ' ' VAL . 25.8 m-85 -56.65 -37.44 70.79 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.507 0.67 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -42.59 -26.29 0.12 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 113.865 -1.516 . . . . 0.0 113.158 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.751 ' O ' HG22 ' A' ' 24' ' ' VAL . . . -124.3 -42.71 2.1 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 124.167 0.917 . . . . 0.0 110.077 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -67.22 -50.85 59.19 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.275 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -61.37 -33.76 74.18 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.697 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.751 HG22 ' O ' ' A' ' 21' ' ' ALA . 2.9 m -54.76 -42.01 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.55 -49.26 38.6 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.3 t -79.99 24.74 0.4 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 -70.1 168.25 15.98 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.213 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.2 pttm -179.79 33.72 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 113.747 -1.57 . . . . 0.0 109.426 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.14 39.88 0.03 OUTLIER Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.001 -1.639 . . . . 0.0 109.001 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.11 -58.39 0.38 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 54.6 mt -61.51 -56.09 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.8 tt -65.05 -30.14 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 114.146 -1.388 . . . . 0.0 108.675 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.88 18.14 27.97 Favored Glycine 0 N--CA 1.494 2.515 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.169 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.6 tp -156.91 82.57 0.94 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.2 t -69.4 -54.71 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.226 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.17 36.26 63.95 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.14 54.57 0.18 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 t -124.28 45.25 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.4 t . . . . . 0 N--CA 1.499 2.016 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.971 179.965 . . . . . . . . 0 0 . 1 stop_ save_